(2R,3S,5R)-5-(6-amino-2-chloro-9H-purin-9-yl)-2-(hydroxymethyl)oxolan-3-ol
| Title | Journal |
|---|---|
| Systems pharmacological analysis of drugs inducing stevens-johnson syndrome and toxic epidermal necrolysis. | Chemical research in toxicology 20150518 |
| Identification of potent Yes1 kinase inhibitors using a library screening approach. | Bioorganic & medicinal chemistry letters 20130801 |
| ABT-737 resistance in B-cells isolated from chronic lymphocytic leukemia patients and leukemia cell lines is overcome by the pleiotropic kinase inhibitor quercetin through Mcl-1 down-regulation. | Biochemical pharmacology 20130401 |
| Topotecan exposure estimation in pediatric acute myeloid leukemia supported by LC-MS-based drug monitoring and pharmacokinetic analysis. | Journal of pharmaceutical and biomedical analysis 20121101 |
| Cladribine is effective against cystic pulmonary Langerhans cell histiocytosis. | American journal of respiratory and critical care medicine 20121101 |
| Fludarabine and cladribine induce changes in surface proteins on human B-lymphoid cell lines involved with apoptosis, cell survival, and antitumor immunity. | Journal of proteome research 20120907 |
| Can ex vivo evaluation (testing) predict the sensitivity of CLL cells to therapy with purine analogs in conjunction with an alkylating agent? A comparison of in vivo and ex vivo responses to treatment. | Medical oncology (Northwood, London, England) 20120901 |
| Changes in the apoptotic gene expression profile in CLL patients treated with rituximab combined with cladribine and cyclophosphamide-preliminary results. | Leukemia research 20120901 |
| Cladribine, but not fludarabine, added to daunorubicin and cytarabine during induction prolongs survival of patients with acute myeloid leukemia: a multicenter, randomized phase III study. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120710 |
| Phosphorylation of deoxycytidine kinase on Ser-74: impact on kinetic properties and nucleoside analog activation in cancer cells. | Biochemical pharmacology 20120701 |
| Poor prognosis of Hodgkin variant of Richter transformation in chronic lymphocytic leukemia treated with cladribine. | British journal of haematology 20120701 |
| Haematological cancer: The rule of three in AML induction--is cladribine the answer? | Nature reviews. Clinical oncology 20120619 |
| Langerhans cell histiocytosis with central nervous system involvement--complete response to 2-chlorodeoxyadenosine after failure of tyrosine kinase inhibitor therapies with sorafenib and imatinib. | Hematological oncology 20120601 |
| Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation. | Bone marrow transplantation 20120601 |
| High incidence of skin rash in patients with hairy cell leukemia treated with cladribine. | Leukemia & lymphoma 20120601 |
| Novel and emerging drugs for acute myeloid leukemia. | Current cancer drug targets 20120601 |
| Langerhans's cell histiocytosis in old subjects: two rare case reports and review of the literature. | Gerodontology 20120601 |
| [Cladribine is highly effective in the treatment of Langerhans cell histiocytosis and rare histiocytic disorders of the juvenile xanthogranuloma group]. | Vnitrni lekarstvi 20120601 |
| Cytotoxic purine nucleoside analogues bind to A1, A2A, and A3 adenosine receptors. | Naunyn-Schmiedeberg's archives of pharmacology 20120501 |
| Role of keratinocytes in the development of vitiligo. | Annals of dermatology 20120501 |
| Treatment of hairy cell leukemia: long-term results in a developing country. | Hematology (Amsterdam, Netherlands) 20120501 |
| ABC transporters and their role in nucleoside and nucleotide drug resistance. | Biochemical pharmacology 20120415 |
| Drugs: An injection of hope. | Nature 20120412 |
| Secondary T-lymphoblastic leukemia in a patient with hairy cell leukemia following cladribine therapy: report of an extremely rare case and review of the literature. | Leukemia & lymphoma 20120401 |
| AMD3100 disrupts the cross-talk between chronic lymphocytic leukemia cells and a mesenchymal stromal or nurse-like cell-based microenvironment: pre-clinical evidence for its association with chronic lymphocytic leukemia treatments. | Haematologica 20120401 |
| Hairy Cell Leukemia and cutaneous involvement. | Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 20120401 |
| Systemic mastocytosis in adults: 2012 Update on diagnosis, risk stratification, and management. | American journal of hematology 20120401 |
| [Interleukin-1 receptor blockade with anakinra provided cessation of fatigue, reduction in inflammation markers and regression of retroperitoneal fibrosis in a patient with Erdheim-Chester disease - case study and a review of literature]. | Vnitrni lekarstvi 20120401 |
| Comparative effects of retinoic acid, vitamin D and resveratrol alone and in combination with adenosine analogues on methylation and expression of phosphatase and tensin homologue tumour suppressor gene in breast cancer cells. | The British journal of nutrition 20120301 |
| Systematic review of purine analog treatment for chronic lymphocytic leukemia: lessons for future trials. | Haematologica 20120301 |
| Fludarabine and rituximab for relapsed or refractory hairy cell leukemia. | Blood 20120301 |
| Phase II study of 2-chlorodeoxyadenosine plus idarubicin for children with acute myeloid leukaemia in first relapse: a paediatric oncology group study. | British journal of haematology 20120301 |
| Running in the family: MALT lymphoma and autoimmune disease in mother and daughter. | World journal of gastrointestinal oncology 20120215 |
| Hairy cell leukemia variant in a patient with chronic myeloid leukemia receiving nilotinib: sequential or coincidental? | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120210 |
| Severe persistent bone marrow failure following therapy with 2-chlorodeoxyadenosine for relapsing juvenile xanthogranuloma of the brain. | Pediatric blood & cancer 20120201 |
| Risk factors for Pneumocystis jirovecii pneumonia in patients with lymphoproliferative disorders. | Clinical lymphoma, myeloma & leukemia 20120201 |
| DNA building blocks: keeping control of manufacture. | Critical reviews in biochemistry and molecular biology 20120201 |
| MiR-181b: new perspective to evaluate disease progression in chronic lymphocytic leukemia. | Oncotarget 20120201 |
| Pulmonary mantle cell lymphoma: a rare manifestation of an uncommon condition. | Rare tumors 20120102 |
| Immune mechanisms of new therapeutic strategies in MS: teriflunomide. | Clinical immunology (Orlando, Fla.) 20120101 |
| Second line chemotherapy in patients with enteropathy-associated T cell lymphoma: a retrospective single center analysis. | Annals of hematology 20120101 |
| Cladribine as a therapeutic option in multiple sclerosis. | Clinical immunology (Orlando, Fla.) 20120101 |
| Reduction in healthcare and societal resource utilization associated with cladribine tablets in patients with relapsing-remitting multiple sclerosis: analysis of economic data from the CLARITY Study. | Clinical drug investigation 20120101 |
| Severe life-threatening or disabling anaphylaxis in patients with systemic mastocytosis: a single-center experience. | International archives of allergy and immunology 20120101 |
| Current status of the immunomodulation and immunomediated therapeutic strategies for multiple sclerosis. | Clinical & developmental immunology 20120101 |
| My treatment approach to hairy cell leukemia. | Mayo Clinic proceedings 20120101 |
| Polo Like Kinase 2 Tumour Suppressor and cancer biomarker: new perspectives on drug sensitivity/resistance in ovarian cancer. | Oncotarget 20120101 |
| The PI3-kinase/mTOR-targeting drug NVP-BEZ235 inhibits growth and IgE-dependent activation of human mast cells and basophils. | PloS one 20120101 |
| A genome-wide study of cytogenetic changes in colorectal cancer using SNP microarrays: opportunities for future personalized treatment. | PloS one 20120101 |
| Pulmonary langerhans cell histiocytosis. | Orphanet journal of rare diseases 20120101 |
| [Lenalidomide induced therapeutic response in a patient with aggressive multi-system Langerhans cell histiocytosis resistant to 2-chloro-deoxyadenosine and early relapsing after high-dose BEAM chemotherapy with autologous peripheral blood stem cell transplantation]. | Vnitrni lekarstvi 20120101 |
| Successful Long Term Eradication of Factor VIII Inhibitor in Patients with Acquired Haemophilia A in Saudi Arabia. | Mediterranean journal of hematology and infectious diseases 20120101 |
| Recombinant T-Cell Receptor Ligand (RTL) for Treatment of Multiple Sclerosis: A Double-Blind, Placebo-Controlled, Phase 1, Dose-Escalation Study. | Autoimmune diseases 20120101 |
| Relapsed and/or Refractory Mantle Cell Lymphoma: What Role for Temsirolimus? | Clinical Medicine Insights. Oncology 20120101 |
| Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. | Current pharmaceutical design 20120101 |
| Immune therapy of multiple sclerosis--future strategies. | Current pharmaceutical design 20120101 |
| Current knowledge on pancreatic cancer. | Frontiers in oncology 20120101 |
| Apoptotic gene expression under influence of fludarabine and cladribine in chronic lymphocytic leukemia-microarray study. | Pharmacological reports : PR 20120101 |
| Novel quinazolinone MJ-29 triggers endoplasmic reticulum stress and intrinsic apoptosis in murine leukemia WEHI-3 cells and inhibits leukemic mice. | PloS one 20120101 |
| Pan-pathway based interaction profiling of FDA-approved nucleoside and nucleobase analogs with enzymes of the human nucleotide metabolism. | PloS one 20120101 |
| Tuberculous meningoencephalitis in a patient with hairy cell leukemia in complete remission. | Journal of clinical and experimental hematopathology : JCEH 20120101 |
| Two Cases of Cerebral Involvement in Malignant Lymphoma (CD20+) That Responded to Combination Therapy with Rituximab and Cladribine. | Case reports in oncology 20120101 |
| [Treatment of Langerhans cells histiocytosis by cladribin reached long-term complete remission in 9 out of 10 adult patients]. | Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti 20120101 |
| Preclinical antitumor activity of thiarabine in human leukemia and lymphoma xenograft models. | Nucleosides, nucleotides & nucleic acids 20120101 |
| [Treatment for recurrent hairy cell leukemia]. | Terapevticheskii arkhiv 20120101 |
| Chronic cladribine administration increases amyloid beta peptide generation and plaque burden in mice. | PloS one 20120101 |
| Cladribine inhibits cytokine secretion by T cells independently of deoxycytidine kinase activity. | Journal of neuroimmunology 20111215 |
| Interferon-alpha is a very effective salvage therapy for patients with hairy cell leukemia relapsing after cladribine: a report of three cases. | Medical oncology (Northwood, London, England) 20111201 |
| Irreversible marrow aplasia after single course of 2-chlorodeoxyadenosine for hairy cell leukaemia preceding by A pandemic 2009-H1N1-associated pneumonia. | Medical oncology (Northwood, London, England) 20111201 |
| Non-gastric marginal zone B cell lymphoma: clinicopathologic features and treatment results. | Annals of hematology 20111201 |
| Current therapeutic options in pediatric multiple sclerosis. | Current treatment options in neurology 20111201 |
| Emerging oral drugs for relapsing-remitting multiple sclerosis. | Expert opinion on emerging drugs 20111201 |
| Structural insights into the inhibition of cytosolic 5'-nucleotidase II (cN-II) by ribonucleoside 5'-monophosphate analogues. | PLoS computational biology 20111201 |
| Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps). | PLoS computational biology 20111201 |
| Clofarabine and high-dose cytosine arabinoside in the treatment of refractory or relapsed acute myeloid leukaemia. | Annals of hematology 20111101 |
| Oral treatment for multiple sclerosis. | The Lancet. Neurology 20111101 |
| Isolation and characterization of a murine P388 leukemia line resistant to clofarabine. | Nucleosides, nucleotides & nucleic acids 20111101 |
| Therapy related acute myeloid leukemia with t(10:16): a rare entity. | Hematology reports 20111019 |
| Phase 2 study of cladribine followed by rituximab in patients with hairy cell leukemia. | Blood 20111006 |
| Mantle cell lymphoma: the promise of new treatment options. | Critical reviews in oncology/hematology 20111001 |
| [38-year-old patient with weight loss and night sweat. Hairy cell leukemia]. | Deutsche medizinische Wochenschrift (1946) 20111001 |
| [MR-documented remission of pituitary stalk infiltration in patients with Langerhans cell histiocytosis following treatment with 2-chlorodeoxyadenosine]. | Vnitrni lekarstvi 20111001 |
| Synthesis and biological evaluation of 2',4'- and 3',4'-bridged nucleoside analogues. | Bioorganic & medicinal chemistry 20110915 |
| The risk of fracture in patients with multiple sclerosis: the UK general practice research database. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20110901 |
| Multiple Sclerosis: The Big Questions- The MS Forum Workshop. | International MS journal 20110901 |
| Seventy-nine-year-old man with Langerhans cell histiocytosis treated with cladribine. | Journal of the American Academy of Dermatology 20110901 |
| Multiple sclerosis: pathogenesis and treatment. | Current neuropharmacology 20110901 |
| Toxicities of immunosuppressive treatment of autoimmune neurologic diseases. | Current neuropharmacology 20110901 |
| Synthesis and significant cytostatic activity of 7-hetaryl-7-deazaadenosines. | Journal of medicinal chemistry 20110811 |
| Effective treatment of leukemia cutis with combination of rituximab, cladribine, and cyclophosphamide in patient with B-cell chronic lymphocytic leukemia. | Annals of hematology 20110801 |
| Cladribine plus rituximab is an effective therapy for newly diagnosed mantle cell lymphoma. | Leukemia & lymphoma 20110801 |
| Epigenetic abnormalities in myeloproliferative neoplasms: a target for novel therapeutic strategies. | Clinical epigenetics 20110801 |
| Multiple sclerosis: Cladribine--a contentious therapeutic contender for MS. | Nature reviews. Neurology 20110712 |
| A case of hairy cell leukemia with CCND1-IGH@ translocation: indolent non-nodal mantle cell lymphoma revisited. | The American journal of surgical pathology 20110701 |
| The therapeutic effect of a pulsed electromagnetic field on the reproductive patterns of male Wistar rats exposed to a 2.45-GHz microwave field. | Clinics (Sao Paulo, Brazil) 20110701 |
| Auto-SCT in refractory celiac disease type II patients unresponsive to cladribine therapy. | Bone marrow transplantation 20110601 |
| Identification of potential surrogate end points in randomized clinical trials of aggressive and indolent non-Hodgkin's lymphoma: correlation of complete response, time-to-event and overall survival end points. | Annals of oncology : official journal of the European Society for Medical Oncology 20110601 |
| A case of mast cell leukaemia with exon 9 KIT mutation and good response to imatinib. | European journal of haematology 20110601 |
| Chemo-immunotherapy for hairy cell leukemia. | Leukemia & lymphoma 20110601 |
| Mechanism of action of pentostatin and cladribine in hairy cell leukemia. | Leukemia & lymphoma 20110601 |
| Implications of minimal residual disease in hairy cell leukemia after cladribine using immunohistochemistry and immunophenotyping. | Leukemia & lymphoma 20110601 |
| Purine analog toxicity in patients with hairy cell leukemia. | Leukemia & lymphoma 20110601 |
| Alternative methods of cladribine administration. | Leukemia & lymphoma 20110601 |
| Rituximab with pentostatin or cladribine: an effective combination treatment for hairy cell leukemia after disease recurrence. | Leukemia & lymphoma 20110601 |
| Insight into the behavior of hairy cell leukemia by immunogenetic analysis. | Leukemia & lymphoma 20110601 |
| Development of cladribine at Scripps for hairy cell leukemia and current results. | Leukemia & lymphoma 20110601 |
| Fifty years of hairy cell leukemia treatments. | Leukemia & lymphoma 20110601 |
| Long-term results for pentostatin and cladribine treatment of hairy cell leukemia. | Leukemia & lymphoma 20110601 |
| Hairy cell leukemia: a successful model for experimental therapeutics--pentostatin and new ideas. | Leukemia & lymphoma 20110601 |
| Hairy cell leukemia: epidemiology, pharmacokinetics of cladribine, and long-term follow-up of subcutaneous therapy. | Leukemia & lymphoma 20110601 |
| Management of hairy cell leukemia variant. | Leukemia & lymphoma 20110601 |
| Recombinant immunotoxins and other therapies for relapsed/refractory hairy cell leukemia. | Leukemia & lymphoma 20110601 |
| Molecular variant of hairy cell leukemia with poor prognosis. | Leukemia & lymphoma 20110601 |
| Hairy cell leukaemia: biological and clinical overview from immunogenetic insights. | Hematological oncology 20110601 |
| [Successful treatment of Erdheim-Chester disease by 2-chlorodeoxyadenosine-based chemotherapy. Two case studies and a literature review]. | Vnitrni lekarstvi 20110601 |
| [Development of new therapies for multiple sclerosis]. | Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20110506 |
| Magnetic resonance imaging as surrogate for clinical endpoints in multiple sclerosis: data on novel oral drugs. | Multiple sclerosis (Houndmills, Basingstoke, England) 20110501 |
| Safety and tolerability of cladribine tablets in multiple sclerosis: the CLARITY (CLAdRIbine Tablets treating multiple sclerosis orallY) study. | Multiple sclerosis (Houndmills, Basingstoke, England) 20110501 |
| Managing MS in a changing treatment landscape. | Journal of neurology 20110501 |
| American academy of neurology annual meeting. | International MS journal 20110501 |
| [Treatment of one hairy cell leukemia case with single course of cladribine]. | Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20110501 |
| Response to cladribine in patient with systemic mastocytosis. | Vojnosanitetski pregled 20110501 |
| A new synthesis of 2-chloro-2'-deoxyadenosine (Cladribine), CdA). | Nucleosides, nucleotides & nucleic acids 20110501 |
| Successful treatment of mucosa-associated lymphoid tissue lymphoma in a patient with gastric and rectal lesions with metachronous and ectopic development. | Rare tumors 20110404 |
| Human biodistribution and radiation dosimetry of novel PET probes targeting the deoxyribonucleoside salvage pathway. | European journal of nuclear medicine and molecular imaging 20110401 |
| Xanthoma disseminatum: effective therapy with 2-chlorodeoxyadenosine in a case series. | Archives of dermatology 20110401 |
| Sustained disease-activity-free status in patients with relapsing-remitting multiple sclerosis treated with cladribine tablets in the CLARITY study: a post-hoc and subgroup analysis. | The Lancet. Neurology 20110401 |
| Systemic mastocytosis in adults: 2011 update on diagnosis, risk stratification, and management. | American journal of hematology 20110401 |
| Clarity and strength of implications for practice in medical journal articles: an exploratory analysis. | BMJ quality & safety 20110401 |
| Comprehensive proteomic analysis of the effects of purine analogs on human Raji B-cell lymphoma. | Journal of proteome research 20110304 |
| Development and validation of a prediction model for the risk of developing febrile neutropenia in the first cycle of chemotherapy among elderly patients with breast, lung, colorectal, and prostate cancer. | Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20110301 |
| Salvaging AML with CLAG: novel option, or more of the same? | Leukemia research 20110301 |
| Salvage chemotherapy regimens for acute myeloid leukemia: Is one better? Efficacy comparison between CLAG and MEC regimens. | Leukemia research 20110301 |
| Nucleoside analogs induce proteasomal down-regulation of p21 in chronic lymphocytic leukemia cell lines. | Biochemical pharmacology 20110301 |
| Cladribine tablets: in relapsing-remitting multiple sclerosis. | CNS drugs 20110301 |
| Principles of a new treatment algorithm in multiple sclerosis. | Expert review of neurotherapeutics 20110301 |
| Modern strategies for hairy cell leukemia. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110210 |
| Resveratrol increases rate of apoptosis caused by purine analogues in malignant lymphocytes of chronic lymphocytic leukemia. | Annals of hematology 20110201 |
| Cladribine combined with rituximab (R-2-CdA) therapy is an effective salvage therapy in relapsed or refractory indolent B-cell non-Hodgkin lymphoma. | European journal of haematology 20110201 |
| Langerhans cell histiocytosis: old disease new treatment. | QJM : monthly journal of the Association of Physicians 20110201 |
| A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma. | Leukemia 20110201 |
| Multiple sclerosis in 2010: Advances in monitoring and treatment of multiple sclerosis. | Nature reviews. Neurology 20110201 |
| Hairy cell leukemia and variant in Taiwan: report of a variant case and literature review. | International journal of clinical and experimental pathology 20110201 |
| Rituximab and subcutaneous 2-chloro-2'-deoxyadenosine as therapy in untreated and relapsed Waldenström's macroglobulinemia. | Clinical lymphoma, myeloma & leukemia 20110201 |
| [Current treatment of multiple sclerosis]. | Lege artis medicinae : uj magyar orvosi hirmondo 20110201 |
| Evaluation of Cladribine treatment in refractory celiac disease type II. | World journal of gastroenterology 20110128 |
| Oral therapies for multiple sclerosis: a review of agents in phase III development or recently approved. | CNS drugs 20110101 |
| Molecular insight into the biology and clinical course of hairy cell leukemia utilizing immunoglobulin gene analysis. | Leukemia & lymphoma 20110101 |
| Therapeutic approach to multiple sclerosis by novel oral drug. | Recent patents on inflammation & allergy drug discovery 20110101 |
| Sex differences in autoimmune diseases. | Biology of sex differences 20110101 |
| Implementation of a new cost efficacy method for blood irradiation using a non dedicated device. | Journal of experimental & clinical cancer research : CR 20110101 |
| Cladribine: mode of action and implications for treatment of multiple sclerosis. | Clinical neuropharmacology 20110101 |
| Use of an online community to develop patient-reported outcome instruments: the Multiple Sclerosis Treatment Adherence Questionnaire (MS-TAQ). | Journal of medical Internet research 20110101 |
| Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options. | Journal of hematology & oncology 20110101 |
| Multiple sclerosis therapeutic pipeline: opportunities and challenges. | The Mount Sinai journal of medicine, New York 20110101 |
| Therapeutics formulated to target cancer stem cells: Is it in our future? | Cancer cell international 20110101 |
| Patient considerations in the management of multiple sclerosis: development and clinical utility of oral agents. | Patient preference and adherence 20110101 |
| Evidence-based assessment of potential use of fingolimod in treatment of relapsing multiple sclerosis. | Core evidence 20110101 |
| Extranodal rosai-dorfman disease with cutaneous and periodontal involvement: a rare presentation. | Case reports in oncology 20110101 |
| Activation of latent HIV using drug-loaded nanoparticles. | PloS one 20110101 |
| The emerging role of ofatumumab in the treatment of chronic lymphocytic leukemia. | Clinical Medicine Insights. Oncology 20110101 |
| Lights and shadows of cyclophosphamide in the treatment of multiple sclerosis. | Autoimmune diseases 20110101 |
| Lymphomatoid granulomatosis treated successfully with rituximab in a renal transplant patient. | Journal of transplantation 20110101 |
| When neurologist and patient disagree on reasonable risk: new challenges in prescribing for patients with multiple sclerosis. | Neuropsychiatric disease and treatment 20110101 |
| Development of oral immunomodulatory agents in the management of multiple sclerosis. | Drug design, development and therapy 20110101 |
| Variations in MALT1 Gene Disruptions Detected by FISH in 109 MALT Lymphomas Occurring in Different Primary Sites. | Journal of the Association of Genetic Technologists 20110101 |
| Therapeutic potential of cladribine in combination with STAT3 inhibitor against multiple myeloma. | BMC cancer 20110101 |
| Unusual manifestation of Erdheim-Chester disease. | BMC gastroenterology 20110101 |
| Bendamustine: safety and efficacy in the management of indolent non-hodgkins lymphoma. | Clinical Medicine Insights. Oncology 20110101 |
| Neonatal systemic juvenile xanthogranuloma with an ominous presentation and successful treatment. | Clinical Medicine Insights. Oncology 20110101 |
| Histiocytosis X: Characteristics, behavior, and treatments as illustrated in a case series. | Surgical neurology international 20110101 |
| Cladribine enhances apoptotic cell death in lung carcinoma cells over-expressing DNase γ. | Biological & pharmaceutical bulletin 20110101 |
| Cerebral localized marginal zone lymphoma presenting as hypothalamic-pituitary region disorder. | Case reports in neurology 20110101 |
| Fingolimod. | Prescrire international 20110101 |
| Cladribine: limited evaluation in multiple sclerosis. | Prescrire international 20110101 |
| Classical hairy cell leukemia and its variant: a 17-year retrospective survey in Taiwan Chinese. | Acta haematologica 20110101 |
| Therapy-Related Myeloid Neoplasms in Chronic Lymphocytic Leukemia and Waldenstrom's Macroglobulinemia. | Mediterranean journal of hematology and infectious diseases 20110101 |
| Targeting VIP and PACAP receptor signalling: new therapeutic strategies in multiple sclerosis. | ASN neuro 20110101 |
| Acute toxicity of the antifouling compound butenolide in non-target organisms. | PloS one 20110101 |
| [A plan for risk management in the treatment of multiple sclerosis with movectro (cladribine tablets)]. | Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20110101 |
| Systematic in-vitro evaluation of the NCI/NIH Developmental Therapeutics Program Approved Oncology Drug Set for the identification of a candidate drug repertoire for MLL-rearranged leukemia. | OncoTargets and therapy 20110101 |
| Disease-modifying drug initiation patterns in commercially insured multiple sclerosis patients: a retrospective cohort study. | BMC neurology 20110101 |
| Drug sensitivity patterns of HHV8 carrying body cavity lymphoma cell lines. | BMC cancer 20110101 |
| Parallel screening of FDA-approved antineoplastic drugs for identifying sensitizers of TRAIL-induced apoptosis in cancer cells. | BMC cancer 20110101 |
| [Partial regression of CNS lesions of Erdheim-Chester disease after treatment with 2-chlorodeoxadenosine and their full remission following treatment with lenalidomide]. | Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti 20110101 |
| Recently confirmed apoptosis-inducing lead compounds isolated from marine sponge of potential relevance in cancer treatment. | Marine drugs 20110101 |
| Establishing long-term efficacy in chronic disease: use of recursive partitioning and propensity score adjustment to estimate outcome in MS. | PloS one 20110101 |
| Efficacy of vinblastine in central nervous system Langerhans cell histiocytosis: a nationwide retrospective study. | Orphanet journal of rare diseases 20110101 |
| Update on celiac disease - etiology, differential diagnosis, drug targets, and management advances. | Clinical and experimental gastroenterology 20110101 |
| Short-Term Relapse Quantitation as a Fully Surrogate Endpoint for Long-Term Sustained Progression of Disability in RRMS Patients Treated with Natalizumab. | Neurology research international 20110101 |
| Dietary phytochemicals, HDAC inhibition, and DNA damage/repair defects in cancer cells. | Clinical epigenetics 20110101 |
| An update on the management of peripheral T-cell lymphoma and emerging treatment options. | Journal of blood medicine 20110101 |
| Cell death signaling and anticancer therapy. | Frontiers in oncology 20110101 |
| Impact of cladribine on soluble adhesion molecules in multiple sclerosis. | Acta neurologica Scandinavica 20101201 |
| A predictive ligand-based Bayesian model for human drug-induced liver injury. | Drug metabolism and disposition: the biological fate of chemicals 20101201 |
| Hairy cell leukemia: current therapies and future directions. | Expert review of hematology 20101201 |
| Simvastatin and purine analogs have a synergic effect on apoptosis of chronic lymphocytic leukemia cells. | Annals of hematology 20101101 |
| Periorbital and ocular necrobiotic xanthogranuloma leading to perforation. | Archives of ophthalmology (Chicago, Ill. : 1960) 20101101 |
| [Lymphoma-like course in aggressive adult multisystem Langerhans cell histiocytosis and the benefit of PET/CT imaging in evaluation of diffuse metabolic activity of lung parenchyma]. | Vnitrni lekarstvi 20101101 |
| Beyond hairy cell: the activity of cladribine in other hematologic malignancies. | Blood 20101021 |
| Hairy cell leukemia: evaluation of the long-term outcome in 121 patients. | Cancer 20101015 |
| [Oral cladribine for relapsing-remitting multiple sclerosis: another purine analogue or a genuine therapeutic innovation?]. | Der Nervenarzt 20101001 |
| Juvenile xanthogranuloma with hematological dysfunction treated with 2CDA-AraC. | Pediatric blood & cancer 20101001 |
| Review of clinical trials conducted in Waldenstrom macroglobulinemia and recommendations for reporting clinical trial responses in these patients. | Leukemia & lymphoma 20101001 |
| What's new in Waldenström macroglobulinemia. | Leukemia & lymphoma 20101001 |
| Current and future role of interferon beta in the therapy of multiple sclerosis. | Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 20101001 |
| Unresolved issues in the comparison of therapies and determination of responses in Waldenström macroglobulinemia. | Leukemia & lymphoma 20101001 |
| Rituximab plus fludarabine and cyclophosphamide or other agents in chronic lymphocytic leukemia. | Expert review of anticancer therapy 20101001 |
| Emerging therapies in relapsing-remitting multiple sclerosis. | Reviews on recent clinical trials 20100901 |
| Emerging oral therapies in multiple sclerosis. | Current neurology and neuroscience reports 20100901 |
| In vitro and in vivo growth-inhibitory effects of cladribine on neoplastic mast cells exhibiting the imatinib-resistant KIT mutation D816V. | Experimental hematology 20100901 |
| Mastocytosis - an update. | Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 20100901 |
| Emerging oral agents for multiple sclerosis. | The American journal of managed care 20100901 |
| Will the newer oral MS agents be welcomed by managed care organizations? | The American journal of managed care 20100901 |
| Chemotherapeutics in the treatment of multiple sclerosis. | Therapeutic advances in neurological disorders 20100901 |
| Chronic progressive multiple sclerosis - pathogenesis of neurodegeneration and therapeutic strategies. | Current neuropharmacology 20100901 |
| Multimodality imaging showing complete cardiovascular involvement by Erdheim-Chester disease. | European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology 20100801 |
| Rituximab and subcutaneous cladribine in chronic lymphocytic leukemia for newly diagnosed and relapsed patients. | Leukemia & lymphoma 20100801 |
| Update on emerging therapies for multiple sclerosis. | Expert review of neurotherapeutics 20100801 |
| Hypomethylation and induction of retinoic acid receptor beta 2 by concurrent action of adenosine analogues and natural compounds in breast cancer cells. | European journal of pharmacology 20100725 |
| Evidence for a two-stage disability progression in multiple sclerosis. | Brain : a journal of neurology 20100701 |
| The natural history of multiple sclerosis: a geographically based study 10: relapses and long-term disability. | Brain : a journal of neurology 20100701 |
| New trends in nucleoside biotechnology. | Acta naturae 20100701 |
| Photodynamic therapy for multi-resistant cutaneous Langerhans cell histiocytosis. | Rare tumors 20100630 |
| [Emerging treatments for multiple sclerosis]. | Revue medicale suisse 20100602 |
| Specific skin lesions in hairy cell leukemia at presentation: case report and review of literature. | Medical oncology (Northwood, London, England) 20100601 |
| A paraneoplastic membranoproliferative glomerulonephritis with isolated C3 deposits associated with hairy cell leukaemia. | Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20100601 |
| Successful treatment of Castleman's disease with interleukin-1 receptor antagonist (Anakinra). | Molecular cancer therapeutics 20100601 |
| The clinico-hematological profile of hairy cell leukaemia: a single centre experience. | Hematology (Amsterdam, Netherlands) 20100601 |
| ACP Journal Club. Oral cladribine was more effective than placebo for relapsing-remitting multiple sclerosis. | Annals of internal medicine 20100518 |
| Oral cladribine and fingolimod for relapsing multiple sclerosis. | The New England journal of medicine 20100506 |
| Oral cladribine and fingolimod for relapsing multiple sclerosis. | The New England journal of medicine 20100506 |
| Diffuse osteosclerosis complicating hairy cell leukemia. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100501 |
| Outcome of pediatric patients with Langerhans cell histiocytosis treated with 2 chlorodeoxyadenosine: a nationwide survey in Japan. | International journal of hematology 20100501 |
| Rituximab and subcutaneous 2-chloro-2'-deoxyadenosine combination treatment for patients with Waldenstrom macroglobulinemia: clinical and biologic results of a phase II multicenter study. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100501 |
| Comparison of cladribine plus cyclophosphamide with fludarabine plus cyclophosphamide as first-line therapy for chronic lymphocytic leukemia: a phase III randomized study by the Polish Adult Leukemia Group (PALG-CLL3 Study). | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100410 |
| Contemporary challenges in mastocytosis. | Clinical reviews in allergy & immunology 20100401 |
| Expression of the human concentrative nucleotide transporter 1 (hCNT1) gene correlates with clinical response in patients affected by Waldenström's Macroglobulinemia (WM) and small lymphocytic lymphoma (SLL) undergoing a combination treatment with 2-chloro-2'-deoxyadenosine (2-CdA) and Rituximab. | Leukemia research 20100401 |
| Significant efficacy of 2-CdA with or without rituximab in the treatment of splenic marginal zone lymphoma (SMZL). | Annals of oncology : official journal of the European Society for Medical Oncology 20100401 |
| The efficacy and stem cell toxicity of cladribine and rituximab in the treatment of patients with chronic lymphocytic leukemia: are all purine analogs created equal? | Leukemia & lymphoma 20100401 |
| Lymphoma--emerging realities in sub-Saharan Africa. | Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 20100401 |
| Efficacy of rituximab and cladribine in patients with chronic lymphocytic leukemia and feasibility of stem cell mobilization: a prospective multicenter phase II trial (protocol SAKK 34/02). | Leukemia & lymphoma 20100401 |
| Orally administered cladribine displays efficacy in multiplesclerosis trial. | Nature reviews. Neurology 20100401 |
| [Development of oral therapies for multiple sclerosis--fingolimod, cladribine and other drugs]. | Medizinische Monatsschrift fur Pharmazeuten 20100401 |
| Current and future disease-modifying therapies in multiple sclerosis. | International journal of clinical practice 20100401 |
| [Fungal infections in oncohematology: the role of prophylaxis]. | Drugs of today (Barcelona, Spain : 1998) 20100401 |
| Very long-term eradication of minimal residual disease in patients with hairy cell leukemia after a single course of cladribine. | Blood 20100311 |
| [Progress of therapy in patients with multiple sclerosis]. | MMW Fortschritte der Medizin 20100304 |
| Apoptosis- and necrosis-induced changes in light attenuation measured by optical coherence tomography. | Lasers in medical science 20100301 |
| CD154 expression triggered by purine analogues in vitro: Correlation with treatment response and autoimmune events in chronic lymphocytic leukemia. | Experimental hematology 20100301 |
| Systemic mastocytosis in adults: a review on prognosis and treatment based on 342 Mayo Clinic patients and current literature. | Current opinion in hematology 20100301 |
| Cladribine tablets: a potential new short-course annual treatment for relapsing multiple sclerosis. | Expert review of neurotherapeutics 20100301 |
| New drugs may improve, complicate treatment for multiple sclerosis. | Nature medicine 20100301 |
| Pathogenesis and Treatment of Anti-MAG Neuropathy. | Current treatment options in neurology 20100301 |
| Oral therapy for multiple sclerosis--sea change or incremental step? | The New England journal of medicine 20100204 |
| A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis. | The New England journal of medicine 20100204 |
| 2CdA chemotherapy and rituximab in the treatment of marginal zone lymphoma. | Leukemia research 20100201 |
| Infectious complications in patients with acute myeloid leukemia treated according to the protocol with daunorubicin and cytarabine with or without addition of cladribine. A multicenter study by the Polish Adult Leukemia Group (PALG). | International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 20100201 |
| Caffeine induces ram sperm hyperactivation independent of cAMP-dependent protein kinase. | International journal of andrology 20100201 |
| Development of oral cladribine for the treatment of multiple sclerosis. | Journal of neurology 20100201 |
| [Cladribin. Development of an oral formulation for the treatment of multiple sclerosis]. | Der Nervenarzt 20100201 |
| [Central diabetes insipidus in adult patients--the first sign of Langerhans cell histiocytosis and Erdheim-Chester disease. Three case studies and literature review]. | Vnitrni lekarstvi 20100201 |
| Clofarabine in leukemia. | Expert review of hematology 20100201 |
| Dural MALT lymphoma with disseminated disease. | Hematology reports 20100126 |
| 6-(Het)aryl-7-deazapurine ribonucleosides as novel potent cytostatic agents. | Journal of medicinal chemistry 20100114 |
| Mitoxantrone and cytotoxic drugs' mechanisms of action. | Neurology 20100105 |
| Emerging multiple sclerosis oral therapies. | Neurology 20100105 |
| Combination of cladribine plus topotecan for recurrent or refractory pediatric acute myeloid leukemia. | Cancer 20100101 |
| R-roscovitine (Seliciclib) affects CLL cells more strongly than combinations of fludarabine or cladribine with cyclophosphamide: Inhibition of CDK7 sensitizes leukemic cells to caspase-dependent apoptosis. | Journal of cellular biochemistry 20100101 |
| The cladribine conundrum: deciphering the drug's mechanism of action. | Expert opinion on drug metabolism & toxicology 20100101 |
| Risk of additional cancers in untreated and treated hairy cell leukemia patients. | Expert opinion on pharmacotherapy 20100101 |
| Inherent and iatrogenic immune defects in hairy cell leukemia: revisited. | Expert opinion on drug safety 20100101 |
| Which role for rituximab in hairy cell leukemia? Reflections on six cases. | Acta haematologica 20100101 |
| Optimizing the benefit of multiple sclerosis therapy: the importance of treatment adherence. | Patient preference and adherence 20100101 |
| Assessment of peripheral blood and bone marrow cells apoptosis caused by purine analogues in patients with chronic lymphocytic leukemia in correlation with parameters of disease progression. | Acta haematologica 20100101 |
| In vivo bioluminescence imaging and histopathopathologic analysis reveal distinct roles for resident and recruited immune effector cells in defense against invasive aspergillosis. | BMC microbiology 20100101 |
| Risks vs benefits of glatiramer acetate: a changing perspective as new therapies emerge for multiple sclerosis. | Therapeutics and clinical risk management 20100101 |
| Determination of genes and microRNAs involved in the resistance to fludarabine in vivo in chronic lymphocytic leukemia. | Molecular cancer 20100101 |
| First-line treatment of chronic lymphocytic leukemia: role of alemtuzumab. | OncoTargets and therapy 20100101 |
| Use of clofarabine for acute childhood leukemia. | Biologics : targets & therapy 20100101 |
| Indeterminate cell histiocytosis in association with acute myeloid leukemia. | Dermatology research and practice 20100101 |
| Identification of targets and new developments in the treatment of multiple sclerosis--focus on cladribine. | Drug design, development and therapy 20100101 |
| Phyllanthus spp. induces selective growth inhibition of PC-3 and MeWo human cancer cells through modulation of cell cycle and induction of apoptosis. | PloS one 20100101 |
| Multiple sclerosis therapies: molecular mechanisms and future. | Results and problems in cell differentiation 20100101 |
| Disease-modifying therapies in relapsing-remitting multiple sclerosis. | Neuropsychiatric disease and treatment 20100101 |
| Emerging oral treatments in multiple sclerosis - clinical utility of cladribine tablets. | Therapeutics and clinical risk management 20100101 |
| Laparoscopic splenectomy for hairy cell leukemia in pregnancy. | Case reports in medicine 20100101 |
| Predicting enzyme targets for cancer drugs by profiling human metabolic reactions in NCI-60 cell lines. | BMC bioinformatics 20100101 |
| Potential short-term use of oral cladribine in treatment of relapsing-remitting multiple sclerosis. | Neuropsychiatric disease and treatment 20100101 |
| The effects of forodesine in murine and human multiple myeloma cells. | Advances in hematology 20100101 |
| New approaches in the management of multiple sclerosis. | Drug design, development and therapy 20100101 |
| Functional brain network changes associated with maintenance of cognitive function in multiple sclerosis. | Frontiers in human neuroscience 20100101 |
| Temsirolimus in the treatment of relapsed and/or refractory mantle cell lymphoma. | Cancer management and research 20100101 |
| Hypotension, Syncope, and Fever in Systemic Mastocytosis without Skin Infiltration and Rapid Response to Corticosteroid and Cyclosporin: A Case Report. | Case reports in medicine 20100101 |
| Rapid Remission in Peripheral T-Cell Lymphoma of the Nasal Type by the Bortezomib plus CHOP Therapy. | Case reports in medicine 20100101 |
| Disease modifying agents for multiple sclerosis. | The open neurology journal 20100101 |
| The spectrum of use of rituximab in chronic lymphocytic leukemia. | OncoTargets and therapy 20100101 |
| Monoclonal antibodies for non-Hodgkin's lymphoma: state of the art and perspectives. | Clinical & developmental immunology 20100101 |
| Cladribine and Fludarabine Nucleoside Change the Levels of CD Antigens on B-Lymphoproliferative Disorders. | International journal of proteomics 20100101 |
| Emerging therapies for treatment of multiple sclerosis. | Journal of inflammation research 20100101 |
| Paraneoplastic pemphigus associated with systemic mastocytosis. | American journal of hematology 20091201 |
| Mechanisms of anti-cancer action and pharmacology of clofarabine. | Biochemical pharmacology 20091201 |
| Spumous histiocytic oligoarthritis coexisting with systemic Langerhans' cell histiocytosis: case report and literature review. | Joint, bone, spine : revue du rhumatisme 20091201 |
| Impaired up-regulation of polo-like kinase 2 in B-cell chronic lymphocytic leukaemia lymphocytes resistant to fludarabine and 2-chlorodeoxyadenosine: a potential marker of defective damage response. | British journal of haematology 20091201 |
| Cytoreductive therapy in 108 adults with systemic mastocytosis: Outcome analysis and response prediction during treatment with interferon-alpha, hydroxyurea, imatinib mesylate or 2-chlorodeoxyadenosine. | American journal of hematology 20091201 |
| On being metachromatic: mystique and misunderstanding in mastocytosis. | American journal of hematology 20091201 |
| Graft-versus-leukemia effect of nonmyeloablative stem cell transplantation. | The Korean journal of internal medicine 20091201 |
| Cladribine inhibits a diltiazem-induced increase in red blood cell purine nucleotide concentrations in a zebrafish model. | Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals 20091201 |
| [Diabetes insipidus followed, after 4 years, with dysarthria and mild right-sided hemiparesis--the first clinical signs of Erdheim-Chester disease. Description and depiction of a case with a review of information on the disease]. | Vnitrni lekarstvi 20091201 |
| Adult celiac disease and its malignant complications. | Gut and liver 20091201 |
| Hairy cell leukemias with unmutated IGHV genes define the minor subset refractory to single-agent cladribine and with more aggressive behavior. | Blood 20091119 |
| VH4-34+ hairy cell leukemia, a new variant with poor prognosis despite standard therapy. | Blood 20091119 |
| Hairy cell leukemia responsive to anti-thymocyte globulin used as immunosuppressive therapy for aplastic anemia. | International journal of hematology 20091101 |
| Cladribine treatment in two-hour intravenous infusion for previously-treated low grade B-cell lymphoma: a pilot study. | Journal of clinical and experimental hematopathology : JCEH 20091101 |
| [Multiple sclerosis, the therapeutic arsenal of today and tomorrow]. | Soins; la revue de reference infirmiere 20091101 |
| Rare lymphoid malignancies of the breast: a report of two cases illustrating potential diagnostic pitfalls. | Journal of hematopathology 20091101 |
| Structure-activity relationships of adenine and deazaadenine derivatives as ligands for adenine receptors, a new purinergic receptor family. | Journal of medicinal chemistry 20091008 |
| Clofarabine: emerging role in leukemias. | Expert opinion on investigational drugs 20091001 |
| The future of multiple sclerosis therapy. | Pharmacological research 20091001 |
| Cladribine in the treatment of hairy cell leukemia: initial and subsequent results. | Leukemia & lymphoma 20091001 |
| Combination therapies to improve the long-term outcome in hairy cell leukemia. | Leukemia & lymphoma 20091001 |
| Long-term follow-up studies in hairy cell leukemia. | Leukemia & lymphoma 20091001 |
| Approach to the patient after relapse of hairy cell leukemia. | Leukemia & lymphoma 20091001 |
| Small-cell lung cancer arising after chemotherapy for a patient with lymphoma of pulmonary mucosa-associated lymphoid tissue-a case report. | Gan to kagaku ryoho. Cancer & chemotherapy 20091001 |
| New oral drugs for multiple sclerosis. | Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20091001 |
| Hairy cell leukemia presenting as multiple discrete hepatic lesions. | World journal of gastroenterology 20090921 |
| Randomized trial of daily versus weekly administration of 2-chlorodeoxyadenosine in patients with hairy cell leukemia: a multicenter phase III trial (SAKK 32/98). | Leukemia & lymphoma 20090901 |
| [Successful treatment of refractory hairy cell leukemia with rituximab]. | Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20090810 |
| Combination of cladribine and cytarabine is effective for childhood acute myeloid leukemia: results of the St Jude AML97 trial. | Leukemia 20090801 |
| Drug cross-resistance and therapy-induced resistance in chronic lymphocytic leukaemia by an enhanced method of individualised tumour response testing. | British journal of haematology 20090801 |
| Cladribine: not just another purine analogue? | Expert opinion on investigational drugs 20090801 |
| Cladribine in the treatment of acute myeloid leukemia: a single-institution experience. | Clinical lymphoma & myeloma 20090801 |
| Roscovitine triggers apoptosis in B-cell chronic lymphocytic leukemia cells with similar efficiency as combinations of conventional purine analogs with cyclophosphamide. | Annals of the New York Academy of Sciences 20090801 |
| Biosynthesis of the salinosporamide A polyketide synthase substrate chloroethylmalonyl-coenzyme A from S-adenosyl-L-methionine. | Proceedings of the National Academy of Sciences of the United States of America 20090728 |
| Novel therapies for peripheral T-cell non-Hodgkin's lymphomas. | Current opinion in hematology 20090701 |
| Phase I/II and pharmacokinetic study of cladribine with 2-h infusion in Japanese patients with relapsed indolent B-cell lymphoma mostly pretreated with rituximab. | Cancer science 20090701 |
| [Hairy cell leukemia: Part II: therapy with cladribine]. | Medizinische Monatsschrift fur Pharmazeuten 20090701 |
| [Design and synthesis of 3'-methyl-furanonucleosides and their anti-tumor activities]. | Yao xue xue bao = Acta pharmaceutica Sinica 20090701 |
| Phase II trial of recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) in patients with hairy cell leukemia. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090620 |
| Transepithelial fluxes of adenosine and 2'-deoxyadenosine across human renal proximal tubule cells: roles of nucleoside transporters hENT1, hENT2, and hCNT3. | American journal of physiology. Renal physiology 20090601 |
| Long-term follow-up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis. | British journal of haematology 20090601 |
| Clofarabine: a new treatment option for patients with acute myeloid leukemia. | Expert opinion on pharmacotherapy 20090601 |
| Effect of parenteral cladribine on relapse rates in patients with relapsing forms of multiple sclerosis: results of a 2-year, double-blind, placebo-controlled, crossover study. | Multiple sclerosis (Houndmills, Basingstoke, England) 20090601 |
| Clofarabine as a novel nucleoside analogue approved to treat patients with haematological malignancies: mechanism of action and clinical activity. | Mini reviews in medicinal chemistry 20090601 |
| Promising outcomes from Phase III CLARITY study for the treatment of multiple sclerosis announced. | Expert review of pharmacoeconomics & outcomes research 20090601 |
| Glucosylceramide synthase inhibitors sensitise CLL cells to cytotoxic agents without reversing P-gp functional activity. | European journal of pharmacology 20090501 |
| The relation between inflammation and neurodegeneration in multiple sclerosis brains. | Brain : a journal of neurology 20090501 |
| Bone marrow CFU-GM and human tumor xenograft efficacy of three antitumor nucleoside analogs. | International journal of oncology 20090501 |
| Differential involvement of reactive oxygen species and nucleoside transporters in cytotoxicity induced by two adenosine analogues in human prostate cancer cells. | The Prostate 20090401 |
| Immunophenotypic analysis of CD103+ B-lymphoproliferative disorders: hairy cell leukemia and its mimics. | American journal of clinical pathology 20090401 |
| Drug induction apoptosis assay as predictive value of chemotherapy response in patients with B-cell chronic lymphocytic leukemia. | Leukemia & lymphoma 20090401 |
| Current status of older and new purine nucleoside analogues in the treatment of lymphoproliferative diseases. | Molecules (Basel, Switzerland) 20090323 |
| Has success spoiled hairy cell leukemia research? Key questions go unanswered, despite big gains. | Journal of the National Cancer Institute 20090318 |
| Successful treatment of central nervous system juvenile xanthogranulomatosis with cladribine. | Pediatric blood & cancer 20090301 |
| Cladribine impedes in vitro migration of mononuclear cells: a possible implication for treating multiple sclerosis. | European journal of neurology 20090301 |
| Progressive diffuse pulmonary Langerhans cell histiocytosis improved by cladribine chemotherapy. | Thorax 20090301 |
| Rituximab-based treatments in Waldenström's macroglobulinemia. | Clinical lymphoma & myeloma 20090301 |
| Calorimetric study as a potential test for choosing treatment of B-cell chronic lymphocytic leukemia. | Leukemia research 20090201 |
| [50-year-old man with weight loss and splenomegaly]. | Deutsche medizinische Wochenschrift (1946) 20090201 |
| [Interdigitating dendritic cell sarcoma of lower extremities resistant to high dose chemotherapy BEAM with peripheral blood stem cell transplantation]. | Vnitrni lekarstvi 20090201 |
| Increased incidence of transformation and myelodysplasia/acute leukemia in patients with Waldenström macroglobulinemia treated with nucleoside analogs. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090110 |
| Valproate synergizes with purine nucleoside analogues to induce apoptosis of B-chronic lymphocytic leukaemia cells. | British journal of haematology 20090101 |
| Concomitant treatment with lamivudine renders cladribine inactive by inhibition of its phosphorylation. | British journal of haematology 20090101 |
| Extranodal multifocal Rosai-Dorfman disease: response to 2-chlorodeoxyadenosine treatment. | International journal of hematology 20090101 |
| Activity of cladribine combined with cyclophosphamide in frontline therapy for chronic lymphocytic leukemia with 17p13.1/TP53 deletion: report from the Polish Adult Leukemia Group. | Cancer 20090101 |
| Treatment of refractory Langerhans cell histiocytosis (LCH) with a combination of 2-chlorodeoxyadenosine and cytosine arabinoside. | Journal of pediatric hematology/oncology 20090101 |
| Low dose 2-chlorodeoxyadenosine given as a single subcutaneous injection in patients with hairy cell leukemia: a multicentre trial SAKK 32/95. | Leukemia & lymphoma 20090101 |
| ARC (NSC 188491) has identical activity to Sangivamycin (NSC 65346) including inhibition of both P-TEFb and PKC. | BMC cancer 20090101 |
| Systemic mastocytosis: classification, pathogenesis, diagnosis, and treatment. | Cutis 20090101 |
| Fludarabine in the treatment of chronic lymphocytic leukemia: a review. | Therapeutics and clinical risk management 20090101 |
| Clinical evaluation of busulfan, cladribine and alemtuzumab as reduced intensity conditioning for stem cell transplantation. | Annals of transplantation 20090101 |
| Paclitaxel alters the expression and specific activity of deoxycytidine kinase and cytidine deaminase in non-small cell lung cancer cell lines. | Journal of experimental & clinical cancer research : CR 20090101 |
| A homoharringtonine-based induction regimen for the treatment of elderly patients with acute myeloid leukemia: a single center experience from China. | Journal of hematology & oncology 20090101 |
| Langerhans cell histiocytosis, a case of Letterer Siwe disease. | The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society 20090101 |
| Drugs associated with more suicidal ideations are also associated with more suicide attempts. | PloS one 20090101 |
| Current and emerging treatments for chronic lymphocytic leukaemia. | Drugs 20090101 |
| Nilotinib: optimal therapy for patients with chronic myeloid leukemia and resistance or intolerance to imatinib. | Drug design, development and therapy 20090101 |
| Characterization of an engineered human purine nucleoside phosphorylase fused to an anti-her2/neu single chain Fv for use in ADEPT. | Journal of experimental & clinical cancer research : CR 20090101 |
| Recent developments in multiple sclerosis therapeutics. | BMC medicine 20090101 |
| Immune hemolytic anemia--selected topics. | Hematology. American Society of Hematology. Education Program 20090101 |
| Development of fludarabine formulations in the treatment of chronic lymphocytic leukemia. | Drug design, development and therapy 20090101 |
| Cost-effectiveness of pentostatin compared with cladribine in the management of hairy cell leukemia in the United Kingdom. | Clinical therapeutics 20090101 |
| Immunopathogenesis of multiple sclerosis. | Annals of Indian Academy of Neurology 20090101 |
| Promising treatments of tomorrow for multiple sclerosis. | Annals of Indian Academy of Neurology 20090101 |
| Profile of nelarabine: use in the treatment of T-cell acute lymphoblastic leukemia. | OncoTargets and therapy 20090101 |
| Bendamustine in the treatment of non-Hodgkin's lymphomas. | OncoTargets and therapy 20090101 |
| New oral disease-modifying therapies for multiple sclerosis. | F1000 medicine reports 20090101 |
| Assessing cost-effectiveness in the management of multiple sclerosis. | ClinicoEconomics and outcomes research : CEOR 20090101 |
| Phase I study of cladribine, cytarabine (Ara-C), granulocyte colony stimulating factor (G-CSF) (CLAG Regimen) and simultaneous escalating doses of imatinib mesylate (Gleevec) in relapsed/refractory AML. | Leukemia research 20081201 |
| [Schnitzler syndrome--report on a fourteen-year course of the disease and an overview of information on the disease]. | Vnitrni lekarstvi 20081201 |
| Rituximab in the treatment of the variant of hairy cell leukaemia: a case report. | Prilozi 20081201 |
| Rituximab in the treatment of non-Hodgkin's lymphoma. | Biologics : targets & therapy 20081201 |
| Clofarabine in refractory Langerhans cell histiocytosis. | Pediatric blood & cancer 20081101 |
| Identification and development of new therapeutics for multiple sclerosis. | Trends in pharmacological sciences 20081101 |
| Paraneoplastic scleroderma secondary to hairy cell leukaemia successfully treated with cladribine. | Rheumatology (Oxford, England) 20081101 |
| Treatment responses to cladribine and dasatinib in rapidly progressing aggressive mastocytosis. | European journal of clinical investigation 20081101 |
| [Langerhans cell histiocytosis in adult patients--a disease with many faces. Experience of a centre and an overview of the disease symptoms]. | Vnitrni lekarstvi 20081101 |
| Synergy of Irofulven in combination with various anti-metabolites, enzyme inhibitors, and miscellaneous agents in MV522 lung carcinoma cells: marked interaction with gemcitabine and 5-fluorouracil. | Investigational new drugs 20081001 |
| Polyadenylation inhibition by the triphosphates of deoxyadenosine analogues. | Leukemia research 20081001 |
| Reduced-intensity unrelated donor bone marrow transplantation for hematologic malignancies. | International journal of hematology 20081001 |
| Hairy cell leukemia: current concepts. | Cancer investigation 20081001 |
| Therapeutic advances in leukemia and myelodysplastic syndrome over the past 40 years. | Cancer 20081001 |
| Impact of T cell chimerism on clinical outcome in 117 patients who underwent allogeneic stem cell transplantation with a busulfan-containing reduced-intensity conditioning regimen. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20081001 |
| Cladribine tablets' potential in multiple: sclerosis treatment. | The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses 20081001 |
| Extranodal hairy cell leukemia presenting in the lumbar spine. | Journal of neurosurgery. Spine 20081001 |
| A case of Mollitias and Fragilitas Ossium - unusual presentation of hairy cell leukaemia followed by the diagnosis of nonsecretory myeloma. | International journal of laboratory hematology 20081001 |
| Characterisation of an inclusion complex between cladribine and 2-hydroxypropyl-beta-cyclodextrin. | Journal of pharmaceutical sciences 20080901 |
| Refractory Waldenström's macroglobulinaemia responsive to 2-chlorodeoxyadenosine and mycophenolate mofetil. | Leukemia research 20080901 |
| Aggressive intermediate cell histiocytosis successfully treated by 2-chlorodeoxyadenosine. | Journal of the European Academy of Dermatology and Venereology : JEADV 20080901 |
| Rituximab in patients with hairy cell leukemia relapsing after treatment with 2-chlorodeoxyadenosine (SAKK 31/98). | Haematologica 20080901 |
| Emerging oral drugs for multiple sclerosis. | Expert opinion on emerging drugs 20080901 |
| Contribution of the drug transporter ABCG2 (breast cancer resistance protein) to resistance against anticancer nucleosides. | Molecular cancer therapeutics 20080901 |
| Advances in the treatment of monoclonal gammopaties: The emerging role of targeted therapy in plasma cell dyscrasias. | Biologics : targets & therapy 20080901 |
| Characterization of acute graft-versus-host disease following reduced-intensity stem-cell transplantation from an HLA-identical related donor. | American journal of hematology 20080801 |
| Elucidation of different binding modes of purine nucleosides to human deoxycytidine kinase. | Journal of medicinal chemistry 20080724 |
| Randomized comparison of cladribine alone or in combination with cyclophosphamide, and cyclophosphamide, vincristine and prednisone in previously untreated low-grade B-cell non-Hodgkin lymphoma patients: final report of the Polish Lymphoma Research Group. | Cancer 20080715 |
| Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis. | Neurology 20080708 |
| Long-term results of the treatment of patients with mantle cell lymphoma with cladribine (2-CDA) alone (95-80-53) or 2-CDA and rituximab (N0189) in the North Central Cancer Treatment Group. | Cancer 20080701 |
| 2-Chloro-2'-deoxyadenosine-induced apoptosis in T leukemia cells is mediated via a caspase-3-dependent mitochondrial feedback amplification loop. | International journal of oncology 20080601 |
| Hairy cell leukemia: treatment successes in the past 25 years. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080601 |
| Cytotoxic activities of nucleoside and nucleobase analog drugs in malignant mesothelioma: characterization of a novel nucleobase transport activity. | Biochemical pharmacology 20080515 |
| Daunorubicin, cytarabine and fludarabine (DAF) for remission induction in relapsed or refractory acute myeloid leukemia. Evaluation of safety, tolerance and early outcome--Polish Adult Leukemia Group (PALG) pilot study. | Annals of hematology 20080501 |
| Hepatosplenic gammadelta T-cell lymphoma successfully treated with a combination of alemtuzumab and cladribine. | Annals of oncology : official journal of the European Society for Medical Oncology 20080501 |
| Central nervous system juvenile xanthogranuloma with malignant transformation. | Pediatric blood & cancer 20080401 |
| Cladribine in indolent non-Hodgkin's lymphoma. | Expert review of anticancer therapy 20080401 |
| Treating refractory leukemias in childhood, role of clofarabine. | Therapeutics and clinical risk management 20080401 |
| Drug transporters: recent advances concerning BCRP and tyrosine kinase inhibitors. | British journal of cancer 20080311 |
| Autologous stem-cell transplantation in malignant multiple sclerosis: a case with a favorable long-term outcome. | Multiple sclerosis (Houndmills, Basingstoke, England) 20080301 |
| Reduced-intensity allogeneic transplant in patients older than 55 years: unrelated umbilical cord blood is safe and effective for patients without a matched related donor. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20080301 |
| Alemtuzumab in the treatment of fludarabine refractory B-cell chronic lymphocytic leukemia (CLL). | Biologics : targets & therapy 20080301 |
| Complete remission of nodular pulmonary Langerhans cell histiocytosis lesions induced by 2-chlorodeoxyadenosine in a non-smoker. | Respiratory medicine 20080201 |
| Cladribine combined with high doses of arabinoside cytosine, mitoxantrone, and G-CSF (CLAG-M) is a highly effective salvage regimen in patients with refractory and relapsed acute myeloid leukemia of the poor risk: a final report of the Polish Adult Leukemia Group. | European journal of haematology 20080201 |
| Analysis of outcome for patients with mass lesions of the central nervous system due to Langerhans cell histiocytosis treated with 2-chlorodeoxyadenosine. | Pediatric blood & cancer 20080101 |
| Hairy cell leukaemia presenting with ascites, pleural effusion and increased CA 125 serum level. | The Netherlands journal of medicine 20080101 |
| Effective treatment of a refractory hairy cell leukemia variant with splenic pre-irradiation and alemtuzumab. | Acta haematologica 20080101 |
| Hairy cell leukemia. | Cancer treatment and research 20080101 |
| [The treatment of Waldenström macroglobulinemia and the therapy of diseases caused by monoclonal IgM gammaglobulin]. | Vnitrni lekarstvi 20080101 |
| Neurotherapeutics in multiple sclerosis: novel agents and emerging treatment strategies. | The Mount Sinai journal of medicine, New York 20080101 |
| Adenosine transporter ENT4 is a direct target of EWS/WT1 translocation product and is highly expressed in desmoplastic small round cell tumor. | PloS one 20080101 |
| Hairy cell leukemia: clinical, pathological and ultrastructural findings in Asian-Indians. | Indian journal of cancer 20080101 |
| Prognostic impact of combined fludarabine, treosulfan and mitoxantrone resistance profile in childhood acute myeloid leukemia. | Anticancer research 20080101 |
| [Synthesis of 2-chloro-2'-deoxyadenosine by microbiological transglycosylation using a recombinant Escherichia coli strain]. | Prikladnaia biokhimiia i mikrobiologiia 20080101 |
| Improved therapeutic effectiveness by combining liposomal honokiol with cisplatin in lung cancer model. | BMC cancer 20080101 |
| Hairy cell leukemia with unusual loss of CD103 in a subset of the neoplastic population: immunophenotypic and cell cycle analysis by flow cytometry. | International journal of clinical and experimental pathology 20080101 |
| Disease-modifying agents for multiple sclerosis: recent advances and future prospects. | Drugs 20080101 |
| Langerhans cell histiocytosis involving the liver of a male smoker: a case report. | Journal of medical case reports 20080101 |
| [Hairy cell leukemia in young patients]. | Terapevticheskii arkhiv 20080101 |
| Pharmacokinetics of cladribine in a rat model following subcutaneous and intra-arterial injections. | Drug metabolism and drug interactions 20080101 |
| Locked-in Syndrome in a Nigerian male with Multiple Sclerosis: a case report and literature review. | The Pan African medical journal 20080101 |
| Complete molecular remission induced by concomitant cladribine--rituximab treatment in a case of multi-resistant hairy cell leukemia. | Leukemia & lymphoma 20071201 |
| Hoogsteen vs. Watson-Crick base pairing: incorporation of 2-substituted adenine- and 7-deazaadenine 2'-deoxy-beta-D-ribonucleosides into oligonucleotides. | Chemistry & biodiversity 20071201 |
| Therapeutic experience of Bing-Neel Syndrome associated with Waldenstrom's macroglobulinemia. | Journal of Korean medical science 20071201 |
| Combined treatment with splenectomy and cladribine in hairy cell leukemia in Taiwan: a clinicopathologic study of 5 cases. | Journal of the Chinese Medical Association : JCMA 20071201 |
| Role of nelarabine in the treatment of T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma. | Therapeutics and clinical risk management 20071201 |
| The role of rituximab in combination with pentostatin or cladribine for the treatment of recurrent/refractory hairy cell leukemia. | Cancer 20071115 |
| The potential role for cladribine in the treatment of multiple sclerosis: clinical experience and development of an oral tablet formulation. | Current medical research and opinion 20071101 |
| [Successful use of cladribine in the treatment of an elderly woman with typical hairy cell leukemia]. | Gan to kagaku ryoho. Cancer & chemotherapy 20071101 |
| Clofarabine: past, present, and future. | Leukemia & lymphoma 20071001 |
| Primary chronic cold agglutinin disease: an update on pathogenesis, clinical features and therapy. | Hematology (Amsterdam, Netherlands) 20071001 |
| Immunosuppressive agents in multiple sclerosis. | Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 20071001 |
| [Combination therapy with rituximab and cladribine for patients with follicular lymphoma]. | Gan to kagaku ryoho. Cancer & chemotherapy 20071001 |
| The disease with hope: hairy cell leukemia. | Clinical journal of oncology nursing 20071001 |
| The epigenetics of mantle cell lymphoma. | Current treatment options in oncology 20071001 |
| [Successful alemtuzumab treatment of a patient with atypical hairy cell leukaemia variant]. | Orvosi hetilap 20070923 |
| Drosophila deoxyribonucleoside kinase mutants with enhanced ability to phosphorylate purine analogs. | Gene therapy 20070901 |
| Cannabinoid receptors expression in bone marrow trephine biopsy of chronic lymphocytic leukaemia patients treated with purine analogues. | Experimental oncology 20070901 |
| [Remarkable response to cladribine in the treatment for hairy B cell lymphoproliferative disorder]. | Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20070810 |
| Chromosomal translocations independently predict treatment failure, treatment-free survival and overall survival in B-cell chronic lymphocytic leukemia patients treated with cladribine. | Leukemia 20070801 |
| Rituximab plus cladribine with or without cyclophosphamide in patients with relapsed or refractory chronic lymphocytic leukemia. | European journal of haematology 20070801 |
| t(14;18)(q32;q21)-bearing pleural MALT lymphoma with IgM paraproteinemia: value of detection of specific cytogenetic abnormalities in the differential diagnosis of MALT lymphoma and lymphoplasmacytic lymphoma. | Hematology (Amsterdam, Netherlands) 20070801 |
| Expansion of regulatory T cells in patients with Langerhans cell histiocytosis. | PLoS medicine 20070801 |
| A single unit lymphoma experience: outcome in a Cape Town academic centre. | Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 20070801 |
| Comparison of fast liquid chromatography/tandem mass spectrometric methods for simultaneous determination of cladribine and clofarabine in mouse plasma. | Journal of pharmaceutical and biomedical analysis 20070628 |
| Cell cycle effect on the activity of deoxynucleoside analogue metabolising enzymes. | Biochemical and biophysical research communications 20070615 |
| Hairy cell leukaemia complicated by anti-MAG paraproteinemic demyelinating neuropathy: resolution of neurological syndrome after cladribrine treatment. | Leukemia research 20070601 |
| Compared benefit of approved and experimental immunosuppressive therapeutic approaches in multiple sclerosis. | Expert opinion on pharmacotherapy 20070601 |
| Cladribine in aggressive forms of multiple sclerosis. | European journal of neurology 20070601 |
| Cladribine combined with cyclophosphamide and mitoxantrone is an active salvage therapy in advanced non-Hodgkin's lymphoma. | Leukemia & lymphoma 20070601 |
| Imatinib and tyrosine kinase inhibition, in the management of BCR-ABL negative myeloproliferative disorders. | Biologics : targets & therapy 20070601 |
| Cladribine in a weekly versus daily schedule for untreated active hairy cell leukemia: final report from the Polish Adult Leukemia Group (PALG) of a prospective, randomized, multicenter trial. | Blood 20070501 |
| Drug resistance in B-cell chronic lymphocytic leukemia: predictable by in vitro evaluation with a multiparameter flow cytometric cytotoxicity assay. | Cytometry. Part B, Clinical cytometry 20070501 |
| Influence of cladribine alone and in combination with cyclophosphamide or cyclophosphamide and mitoxantrone on bone marrow angiogenesis in chronic lymphocytic leukemia. | Leukemia & lymphoma 20070501 |
| Systemic mastocytosis: a concise clinical and laboratory review. | Archives of pathology & laboratory medicine 20070501 |
| Novel oral agents for multiple sclerosis. | Current neurology and neuroscience reports 20070501 |
| Dihydrodiol dehydrogenase in drug resistance and sensitivity of human carcinomas. | Cancer chemotherapy and pharmacology 20070401 |
| Current treatment options in prolymphocytic leukemia. | Medical science monitor : international medical journal of experimental and clinical research 20070401 |
| Hairy Cell Leukemia. | Current treatment options in oncology 20070401 |
| Presence of the anti-leukemic nucleotide analog, 2-chloro-2'-deoxyadenosine-5'-monophosphate, in a promoter sequence alters DNA binding of TATA-binding protein (TBP). | Archives of biochemistry and biophysics 20070315 |
| Two novel nucleoside ester derivatives of chlorambucil as potential antileukemic prodrugs: a preliminary study. | Anti-cancer drugs 20070301 |
| Complete response in a patient with colonic mantle cell lymphoma with multiple lymphomatous polyposis treated with combination chemotherapy using anti-CD20 antibody and cladribine. | Gut 20070301 |
| Update on the management of refractory coeliac disease. | Journal of gastrointestinal and liver diseases : JGLD 20070301 |
| Membrane localization and pH-dependent transport of a newly cloned organic cation transporter (PMAT) in kidney cells. | American journal of physiology. Renal physiology 20070201 |
| Pharmacological inhibition of the MAPK/ERK pathway increases sensitivity to 2-chloro-2'-deoxyadenosine (CdA) in the B-cell leukemia cell line EHEB. | Biochemical pharmacology 20070201 |
| Fludarabine vs cladribine plus busulfan and low-dose TBI as reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation: a prospective randomized trial. | Bone marrow transplantation 20070201 |
| Effect of frequently used chemotherapeutic drugs on the cytotoxic activity of human natural killer cells. | Molecular cancer therapeutics 20070201 |
| The multicenter trial SAKK 37/95 of cladribine, cyclophosphamide and prednisone in the treatment of chronic lymphocytic leukemias and low-grade non-Hodgkin's lymphomas. | Acta haematologica 20070101 |
| Langerhans cell histiocytosis of vulva in adolescent. | International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20070101 |
| A novel small molecule that selectively inhibits glioblastoma cells expressing EGFRvIII. | Molecular cancer 20070101 |
| Development of hairy cell leukemia in a patient with antiphospholipid syndrome. | Lupus 20070101 |
| Oral disease-modifying treatments for multiple sclerosis: the story so far. | CNS drugs 20070101 |
| [Treatment of hairy cell leukemia with cladribine]. | Lijecnicki vjesnik 20070101 |
| I have good news! You have leukemia. | Clinics in dermatology 20070101 |
| Development and validation of a sensitive and specific HPLC assay of cladribine for pharmacokinetics studies in rats. | Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques 20070101 |
| The management of complicated celiac disease. | Digestive diseases (Basel, Switzerland) 20070101 |
| Development and validation of an assay for the quantitative determination of cladribine nucleotides in MDCKII cells and culture medium using weak anion-exchange liquid chromatography coupled with tandem mass spectrometry. | Rapid communications in mass spectrometry : RCM 20070101 |
| Hypereosinophilic syndrome, chronic eosinophilic leukemia, and mast cell disease. | Cancer journal (Sudbury, Mass.) 20070101 |
| The effects of nucleoside analogues on promoter methylation of selected tumor suppressor genes in MCF-7 and MDA-MB-231 breast cancer cell lines. | Nucleosides, nucleotides & nucleic acids 20070101 |
| [Therapeutically relevant mutations in the receptor tyrosine kinase KIT in mastocytosis]. | Verhandlungen der Deutschen Gesellschaft fur Pathologie 20070101 |
| Activity and toxicity of 2-CDA in Langerhans cell histiocytosis: a single institutional experience. | Indian journal of cancer 20070101 |
| Neglected respiratory toxicity caused by cancer therapy. | The open respiratory medicine journal 20070101 |
| Prolonged follow-up after initial therapy with 2-chlorodeoxyadenosine in patients with indolent non-Hodgkin lymphoma: results of Cancer and Leukemia Group B Study 9153. | Cancer 20061215 |
| Lipid raft disruption prevents apoptosis induced by 2-chloro-2'-deoxyadenosine (Cladribine) in leukemia cell lines. | Leukemia research 20061201 |
| In vitro sensitivity of B-cell chronic lymphocytic leukemia to cladribine and its combinations with mafosfamide and/or mitoxantrone. | Oncology reports 20061201 |
| Cytotoxic effect of R-etodolac (SDX-101) in combination with purine analogs or monoclonal antibodies on ex vivo B-cell chronic lymphocytic leukemia cells. | Leukemia & lymphoma 20061201 |
| Dramatic clinical efficacy of cladribine in Rosai-Dorfman disease and evolution of the cytokine profile: towards a new therapeutic approach. | Haematologica 20061201 |
| [Mastocytosis--mastcell proliferative disease risk of anaphylactic reaction]. | Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20061201 |
| Efficacy of low dose clofarabine in refractory precursor T- acute lymphoblastic leukemia. | The Yale journal of biology and medicine 20061201 |
| Prolonged clinical remission in patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type treated with cladribine: 6 year follow-up of a phase II trial. | Annals of oncology : official journal of the European Society for Medical Oncology 20061101 |
| Cladribine therapy in refractory celiac disease with aberrant T cells. | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20061101 |
| 2-CdA in the treatment of hairy cell leukemia: a review of long-term follow-up. | Leukemia & lymphoma 20061101 |
| Treatment of clonal refractory celiac disease or cryptic intraepithelial lymphoma: A long road from bench to bedside. | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20061101 |
| Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease) treated with 2-chlorodeoxyadenosine. | Pediatric blood & cancer 20061015 |
| Novel approaches in the treatment of systemic mastocytosis. | Cancer 20061001 |
| Rituximab combined with cladribine or with cladribine and cyclophosphamide in heavily pretreated patients with indolent lymphoproliferative disorders and mantle cell lymphoma. | Cancer 20061001 |
| Cladribine: an investigational immunomodulatory agent for multiple sclerosis. | The Annals of pharmacotherapy 20061001 |
| Pentostatin: impact on outcome in hairy cell leukemia. | Hematology/oncology clinics of North America 20061001 |
| Cladribine in hairy cell leukemia. | Hematology/oncology clinics of North America 20061001 |
| [Successful salvage therapy with cladribine and rituximab for a patient with a relapsed Asian variant of intravascular large B-cell lymphoma]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 20061001 |
| New directions in the treatment of mantle cell lymphoma: an overview. | Clinical lymphoma & myeloma 20061001 |
| Regiospecific and highly stereoselective coupling of 6-(substituted-imidazol-1-yl)purines with 2-deoxy-3,5-di-O-(p-toluoyl)-alpha-D-erythro-pentofuranosyl chloride. Sodium-salt glycosylation in binary solvent mixtures: improved synthesis of cladribine. | The Journal of organic chemistry 20060929 |
| Molecular determinants of specificity for synthetic nucleoside analogs in the concentrative nucleoside transporter, CNT2. | The Journal of biological chemistry 20060908 |
| Hairy cell leukemia. | Current oncology reports 20060901 |
| Treatment of recurrent Langerhans cell histiocytosis in children with 2-chlorodeoxyadenosine. | Leukemia & lymphoma 20060901 |
| Severe neuropathy in a patient with Waldenstrom disease: from a challenging diagnosis to clinical improvement by innovative therapy. | Leukemia & lymphoma 20060901 |
| Asparaginase (native ASNase or pegylated ASNase) in the treatment of acute lymphoblastic leukemia. | International journal of nanomedicine 20060901 |
| In vitro synergistic cytotoxicity of gemcitabine and pemetrexed and pharmacogenetic evaluation of response to gemcitabine in bladder cancer patients. | British journal of cancer 20060807 |
| Current treatment options in hairy cell leukemia and hairy cell leukemia variant. | Cancer treatment reviews 20060801 |
| Single-agent purine analogues for the treatment of chronic lymphocytic leukaemia: a systematic review and meta-analysis. | Cancer treatment reviews 20060801 |
| Role of interferon-alpha administration after 2-deoxycoformycin in the treatment of hairy cell leukemia patients. | European journal of haematology 20060801 |
| KIT mutations in mastocytosis and their potential as therapeutic targets. | Immunology and allergy clinics of North America 20060801 |
| High activity of rituximab combined with cladribine and cyclophosphamide in a patient with pulmonary lymphomatoid granulomatosis and bone marrow involvement. | Leukemia & lymphoma 20060801 |
| Hairy-cell leukaemia: first-line treatment with cladribine or pentostatin. | Prescrire international 20060801 |
| Multiply relapsing hairy cell leukemia responsive to repeated courses of rituximab: a case report. | Hematology (Amsterdam, Netherlands) 20060801 |
| Purine antagonists for chronic lymphocytic leukaemia. | The Cochrane database of systematic reviews 20060719 |
| Cladribine alone and in combination with cyclophosphamide or cyclophosphamide plus mitoxantrone in the treatment of progressive chronic lymphocytic leukemia: report of a prospective, multicenter, randomized trial of the Polish Adult Leukemia Group (PALG CLL2). | Blood 20060715 |
| Enforced expression of cytosolic 5'-nucleotidase I confers resistance to nucleoside analogues in vitro but systemic chemotherapy toxicity precludes in vivo selection. | Cancer chemotherapy and pharmacology 20060701 |
| Clinical and pharmacokinetic study of clofarabine in chronic lymphocytic leukemia: strategy for treatment. | Clinical cancer research : an official journal of the American Association for Cancer Research 20060701 |
| [Pulmonary cryptococcosis occurring 6 months after cladribine therapy for relapsed follicular lymphoma]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 20060701 |
| AMN107 (nilotinib): a novel and selective inhibitor of BCR-ABL. | British journal of cancer 20060619 |
| Eradication of minimal residual disease in hairy cell leukemia. | Blood 20060615 |
| [Hypersensitivity reactions to multiple drugs during the course of hairy cell leukemia treated with 2-chlorodeoxyadenosine]. | Arerugi = [Allergy] 20060601 |
| [Waldemström s macroglobulinemia]. | Anales de medicina interna (Madrid, Spain : 1984) 20060601 |
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. | Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501 |
| New agents in chronic lymphocytic leukemia. | Current treatment options in oncology 20060501 |
| Cryptococcus neoformans meningitis in a patient with hairy cell leukemia. | American journal of hematology 20060501 |
| The role of purine analogues in low-intensity regimens with allogeneic hematopoietic stem cell transplantation. | Seminars in hematology 20060401 |
| Update on extranodal lymphomas. Conclusions of the Workshop held by the EAHP and the SH in Thessaloniki, Greece. | Histopathology 20060401 |
| [Histiocytosis from Langerhans cell in adults--experience of one department and review of treatment alternatives]. | Vnitrni lekarstvi 20060401 |
| The pattern of deoxycytidine- and deoxyguanosine kinase activity in relation to messenger RNA expression in blood cells from untreated patients with B-cell chronic lymphocytic leukemia. | Biochemical pharmacology 20060314 |
| Accumulation of irreversible disability in multiple sclerosis: from epidemiology to treatment. | Clinical neurology and neurosurgery 20060301 |
| Guidelines on the management of Waldenström macroglobulinaemia. | British journal of haematology 20060301 |
| Potential predictive patterns of minimal residual disease detected by immunohistochemistry on bone marrow biopsy specimens during a long-term follow-up in patients treated with cladribine for hairy cell leukemia. | Archives of pathology & laboratory medicine 20060301 |
| Advances in the treatment of chronic lymphocytic leukemia. | Current hematologic malignancy reports 20060301 |
| Effects of drug combinations on smooth muscle cell proliferation: an isobolographic analysis. | European journal of pharmacology 20060217 |
| Development of hairy cell leukemia in a patient after cardiac transplantation. | Leukemia & lymphoma 20060201 |
| The structure of human deoxycytidine kinase in complex with clofarabine reveals key interactions for prodrug activation. | Acta crystallographica. Section D, Biological crystallography 20060201 |
| Transformation and progression of Waldenström's macroglobulinemia following cladribine therapy in two cases: natural evolution or iatrogenic causation? | American journal of hematology 20060201 |
| Future perspectives in the treatment of cutaneous T-cell lymphoma (CTCL). | Seminars in oncology 20060201 |
| CASE 1. Langerhans cell histiocytosis of the thyroid. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060120 |
| PKC412 inhibits in vitro growth of neoplastic human mast cells expressing the D816V-mutated variant of KIT: comparison with AMN107, imatinib, and cladribine (2CdA) and evaluation of cooperative drug effects. | Blood 20060115 |
| A comparison of the transportability, and its role in cytotoxicity, of clofarabine, cladribine, and fludarabine by recombinant human nucleoside transporters produced in three model expression systems. | Molecular pharmacology 20060101 |
| Concomitant hairy cell and acute myeloid leukemia. | European journal of haematology 20060101 |
| PRIMA-1 induces apoptosis in acute myeloid leukaemia cells with p53 gene deletion. | British journal of haematology 20060101 |
| Early-onset autoimmune hemolytic anemia after cladribine therapy for Waldenström's macroglobulinemia. | Transfusion 20060101 |
| Hairy cell leukemia: a diagnosis by endoscopic ultrasound guided fine needle aspiration. | CytoJournal 20060101 |
| In vitro sensitivity and cross-resistance to deoxynucleoside analogs in childhood acute leukemia. | Haematologica 20060101 |
| The relation between deoxycytidine kinase activity and the radiosensitising effect of gemcitabine in eight different human tumour cell lines. | BMC cancer 20060101 |
| Efficacy and tolerability of gemtuzumab ozogamicin (anti-CD33 monoclonal antibody, CMA-676, Mylotarg) in children with relapsed/refractory myeloid leukemia. | BMC cancer 20060101 |
| Hairy cell leukemia: an elusive but treatable disease. | The oncologist 20060101 |
| Multiple opportunistic infections after high-dose steroid therapy for giant cell arteritis in a patient previously treated with a purine analog. | Scandinavian journal of infectious diseases 20060101 |
| Cellular resistance against troxacitabine in human cell lines and pediatric patient acute myeloid leukemia blast cells. | Nucleosides, nucleotides & nucleic acids 20060101 |
| Study of the efficacy of a pronucleotide of 2-chloro-2'-deoxyadenosine in deoxycytidine kinase-deficient lymphoma cells. | Nucleosides, nucleotides & nucleic acids 20060101 |
| Micro-array analysis of resistance for gemcitabine results in increased expression of ribonucleotide reductase subunits. | Nucleosides, nucleotides & nucleic acids 20060101 |
| Inhibition of the ERK pathway promotes apoptosis induced by 2-chloro-2'-deoxyadenosine in the B-cell leukemia cell line EHEB. | Nucleosides, nucleotides & nucleic acids 20060101 |
| Alteration of DNA methylation status in K562 and MCF-7 cancer cell lines by nucleoside analogues. | Nucleosides, nucleotides & nucleic acids 20060101 |
| Cytotoxic drug sensitivity of Epstein-Barr virus transformed lymphoblastoid B-cells. | BMC cancer 20060101 |
| Hairy-cell leukemia: a rare blood disorder in Asia. | The Southeast Asian journal of tropical medicine and public health 20060101 |
| Older and new formulations of cladribine. Pharmacology and clinical efficacy in hematological malignancies. | Recent patents on anti-cancer drug discovery 20060101 |
| Recent clinical trials of cladribine in hematological malignancies and autoimmune disorders. | Reviews on recent clinical trials 20060101 |
| The human equilibrative nucleoside transporter 1 mediates in vitro cytarabine sensitivity in childhood acute myeloid leukaemia. | British journal of cancer 20051212 |
| Long remissions in hairy cell leukemia with purine analogs: a report of 219 patients with a median follow-up of 12.5 years. | Cancer 20051201 |
| Clofarabine in the treatment of acute myeloid leukaemia and acute lymphoblastic leukaemia: a review. | Expert opinion on pharmacotherapy 20051201 |
| Addition of cladribine to induction/consolidation regimen does not impair peripheral blood stem cell mobilization and bone marrow harvest for autotransplantation in acute myeloid leukemia patients. | Transplantation proceedings 20051201 |
| Asymmetries in the spatial distributions of enhancing lesions and black holes in relapsing-remitting MS. | Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 20051101 |
| Drug therapy for the treatment of Langerhans cell histiocytosis. | Expert opinion on pharmacotherapy 20051101 |
| Complete remission of hairy cell leukemia variant (HCL-v) complicated by red cell aplasia post treatment with rituximab. | Haematologica 20051101 |
| Cladribine for multiple sclerosis: review and current status. | Expert review of neurotherapeutics 20051101 |
| Mast cell leukaemia. | British journal of haematology 20051101 |
| Multi-centre pilot study of 2-chlorodeoxyadenosine and cytosine arabinoside combined chemotherapy in refractory Langerhans cell histiocytosis with haematological dysfunction. | European journal of cancer (Oxford, England : 1990) 20051101 |
| [Successful treatment with cladribine for hypoplastic hairy cell leukemia after long-term neutropenia]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 20051101 |
| [Successful rituximab treatment in a patient with refractory hairy cell leukemia-Japanese variant and suffering from acute respiratory distress]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 20051101 |
| [Systemic mastocytosis]. | La Revue du praticien 20051015 |
| Severe, refractory type II essential mixed cryoglobulinemia treated with 2-chlorodeoxyadenosine and mycophenolate mofetil. | Rheumatology international 20051001 |
| Cladribine therapy in a patient with an aleukemic subvariant of mast cell leukemia. | Annals of hematology 20051001 |
| Old and new insights into the mechanisms of action of two nucleoside analogs active in lymphoid malignancies: fludarabine and cladribine (review). | International journal of oncology 20051001 |
| High activity and incomplete cross resistance of nucleoside analogues cladribine and fludarabine versus Ara-C on leukemic cells from patients with AML. | Therapeutic drug monitoring 20051001 |
| Comparison of cladribine plus prednisone with chlorambucil plus prednisone in patients with chronic lymphocytic leukemia. Final report of the Polish Adult Leukemia Group (PALG CLL1). | Medical science monitor : international medical journal of experimental and clinical research 20051001 |
| Potentiation of in vitro ara-C cytotoxicity by ribonucleotide reductase inhibitors, cyclin-dependent kinase modulators and the DNA repair inhibitor aphidicolin in paediatric acute myeloid leukaemia. | British journal of haematology 20051001 |
| Phase II clinical study of cladribine in the treatment of hairy cell leukemia. | International journal of hematology 20051001 |
| [Case of intraspinal epidural tumor developing after systemic mastocytosis with marked osteosclerosis and myelofibrosis]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 20051001 |
| A multicenter, open, noncomparative, phase II study of the combination of cladribine (2-chlorodeoxyadenosine), cytarabine, granulocyte colony-stimulating factor and mitoxantrone as induction therapy in refractory acute myeloid leukemia: a report of the Polish Adult Leukemia Group. | Annals of hematology 20050901 |
| Quantitation of synergism of arabinosylcytosine and cladribine against the growth of arabinosylcytosine-resistant human lymphoid cells. | Journal of cancer research and clinical oncology 20050901 |
| Advances in the treatment of chronic lymphocytic leukemia. | Current oncology reports 20050901 |
| History of modern multiple sclerosis therapy. | Journal of neurology 20050901 |
| Identification of molecular mechanisms for cellular drug resistance by combining drug activity and gene expression profiles. | British journal of cancer 20050822 |
| Cytosine arabinoside affects multiple cellular factors and induces drug resistance in human lymphoid cells. | Biochemical pharmacology 20050801 |
| 2-Chlorodeoxyadenosine and cytarabine combination therapy for idiopathic hypereosinophilic syndrome. | Cancer 20050801 |
| Hairy cell leukemia (HCL) with extensive myelofibrosis responds to thalidomide. | Leukemia research 20050801 |
| Activity of cladribine combined with etoposide in heavily pretreated patients with indolent lymphoid malignancies. | Chemotherapy 20050801 |
| The natural product honokiol induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) cells. | Blood 20050715 |
| Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA): long-term follow-up of the Northwestern University experience. | Blood 20050701 |
| Docking simulation with a purine nucleoside specific homology model of deoxycytidine kinase, a target enzyme for anticancer and antiviral therapy. | Bioorganic & medicinal chemistry 20050701 |
| The effect of subsequent therapies in patients with chronic lymphocytic leukemia previously treated with prednisone and either cladribine or chlorambucil. | Haematologica 20050701 |
| Chemotherapeutic experience in indeterminate cell histiocytosis. | The British journal of dermatology 20050701 |
| Merkel cell carcinoma in a patient with B-cell chronic lymphocytic leukemia treated with cladribine and rituximab. | Leukemia & lymphoma 20050601 |
| The role of clofarabine in hematologic and solid malignancies--development of a next-generation nucleoside analog. | Cancer 20050515 |
| [Systemic mastocytosis]. | Presse medicale (Paris, France : 1983) 20050514 |
| In vitro cytotoxic effect of proteasome inhibitor bortezomib in combination with purine nucleoside analogues on chronic lymphocytic leukaemia cells. | European journal of haematology 20050501 |
| Hairy cell leukemia: clinical presentation and long term follow up after treatment with 2-chlorodeoxyadenosine (2-CdA). | JPMA. The Journal of the Pakistan Medical Association 20050501 |
| Successful treatment of extranodal Hodgkin's lymphoma in a patient with longstanding hairy cell leukemia. | Leukemia & lymphoma 20050501 |
| Functional characterization of novel human and mouse equilibrative nucleoside transporters (hENT3 and mENT3) located in intracellular membranes. | The Journal of biological chemistry 20050422 |
| Activation of deoxycytidine kinase by deoxyadenosine: implications in deoxyadenosine-mediated cytotoxicity. | Archives of biochemistry and biophysics 20050401 |
| An analysis of the utilisation of chemoprophylaxis against Pneumocystis jirovecii pneumonia in patients with malignancy receiving corticosteroid therapy at a cancer hospital. | British journal of cancer 20050314 |
| [Systemic mastocytosis]. | Deutsche medizinische Wochenschrift (1946) 20050304 |
| Langerhans cell histiocytosis with central nervous system involvement: follow-up by FDG-PET during treatment with cladribine. | Pediatric blood & cancer 20050301 |
| In vitro drug resistance in B cell chronic lymphocytic leukemia: a comparison with acute myelocytic and acute lymphocytic leukemia. | Anti-cancer drugs 20050301 |
| Diagnosis and management of Waldenstrom's macroglobulinemia. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050301 |
| [Metabolism, mechanism of action and resistance to cytotoxic nucleoside analogues]. | Bulletin du cancer 20050301 |
| The place of cladribine in the treatment of chronic lymphocytic leukemia: a 10-year experience in Poland. | Annals of hematology 20050201 |
| Long-term analysis of the palliative benefit of 2-chlorodeoxyadenosine for myelofibrosis with myeloid metaplasia. | European journal of haematology 20050201 |
| Therapy of chronic lymphocytic leukemia with purine analogs and monoclonal antibodies. | Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 20050201 |
| Hairy cell leukemia: survival and relapse. Long-term follow-up of purine analog-based therapy and approach for relapsed disease. | Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 20050201 |
| Proapoptotic activity of alemtuzumab alone and in combination with rituximab or purine nucleoside analogues in chronic lymphocytic leukemia cells. | Leukemia & lymphoma 20050101 |
| Changes in leukemic cell nuclei revealed by differential scanning calorimetry. | Leukemia & lymphoma 20050101 |
| How we treat Waldenström's macroglobulinemia. | Haematologica 20050101 |
| Functional analysis of genetic variants in the human concentrative nucleoside transporter 3 (CNT3; SLC28A3). | The pharmacogenomics journal 20050101 |
| In vitro sensitivity of leukemic cells to nucleoside derivatives in childhood acute leukemias: good activity in leukemic relapses. | Neoplasma 20050101 |
| A2B adenosine receptor activity is reduced in neutrophils from patients with systemic sclerosis. | Arthritis research & therapy 20050101 |
| Application of population pharmacokinetics to cladribine. | BMC pharmacology 20050101 |
| Primary progressive multiple sclerosis : current and future treatment options. | CNS drugs 20050101 |
| Cytotoxic effects of cladribine and tezacitabine toward HL-60. | Acta biochimica Polonica 20050101 |
| Determination of caspase-3 activation fails to predict chemosensitivity in primary acute myeloid leukemia blasts. | BMC cancer 20050101 |
| Modern diagnosis and treatment of primary eosinophilia. | Acta haematologica 20050101 |
| Waldenström's macroglobulinemia. | Best practice & research. Clinical haematology 20050101 |
| Enhanced efficacy of gemcitabine in combination with anti-CD20 monoclonal antibody against CD20+ non-Hodgkin's lymphoma cell lines in vitro and in scid mice. | BMC cancer 20050101 |
| In B-CLL, the codon 72 polymorphic variants of p53 are not related to drug resistance and disease prognosis. | BMC cancer 20050101 |
| Efficient chemo-enzymatic syntheses of pharmaceutically useful unnatural 2'-deoxynucleosides. | Nucleosides, nucleotides & nucleic acids 20050101 |
| [Future possibilities of the multiple sclerosis treatment]. | Casopis lekaru ceskych 20050101 |
| Simultaneous quantification of fludarabine and cyclophosphamide in human plasma by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry. | Rapid communications in mass spectrometry : RCM 20050101 |
| [Treatment results of Langerhans cell histiocytosis with LSH II protocol]. | Casopis lekaru ceskych 20050101 |
| Therapy of chronic lymphocytic leukaemia with purine nucleoside analogues: facts and controversies. | Drugs & aging 20050101 |
| Aggressive central nervous system demyelination in an adolescent. | Reviews in neurological diseases 20050101 |
| Synthesis and preliminary in vitro evaluation of 5'-O-esters of 2'-deoxyadenosine and 2-chloro-2'-deoxyadenosine with alpha-lipoic acid as potential prodrugs. | Acta poloniae pharmaceutica 20050101 |
| [Progress and perspectives in the treatment of systemic lupus erythematosus]. | Przeglad lekarski 20050101 |
| Adenine deoxynucleotides fludarabine and cladribine induce apoptosis in a CD95/Fas receptor, FADD and caspase-8-independent manner by activation of the mitochondrial cell death pathway. | Oncogene 20041216 |
| A phase I trial of gemcitabine plus cladribine in patients with advanced hematologic malignant diseases. | Cancer chemotherapy and pharmacology 20041201 |
| VH gene mutation status and cellular drug resistance in chronic lymphocytic leukaemia. | European journal of haematology 20041201 |
| Rituximab as treatment for minimal residual disease in hairy cell leukaemia. | European journal of haematology 20041201 |
| The influence of farnesyl protein transferase inhibitor R115777 (Zarnestra) alone and in combination with purine nucleoside analogs on acute myeloid leukemia progenitors in vitro. | European journal of haematology 20041201 |
| Transient complete atrioventricular block after cladribine administration. | International journal of cardiology 20041201 |
| [nhibitory effect of adenosine analogues on invasion of human ovarian cancer cell line HO-8910PM]. | Ai zheng = Aizheng = Chinese journal of cancer 20041201 |
| Treatment options in Waldenstrom's macroglobulinemia. | Clinical lymphoma 20041201 |
| Successful induction of long-term remission using rituximab in a patient with refractory hairy cell leukemia-Japanese variant. | International journal of hematology 20041201 |
| Management of patients with systemic mastocytosis: review of M. D. Anderson Cancer Center experience. | American journal of hematology 20041101 |
| Acquired factor VIII inhibitors in non-haemophilic patients: clinical experience of 15 cases. | Haemophilia : the official journal of the World Federation of Hemophilia 20041101 |
| The influence of chemotherapy on bone marrow in patients with chronic lymphocytic leukaemia. | Folia morphologica 20041101 |
| Farnesyltransferase inhibitor BMS-214662 induces apoptosis in B-cell chronic lymphocytic leukemia cells. | Leukemia 20041001 |
| Acute myeloid leukemia following treatment with cladribine for hairy cell leukemia: a case report and review of the literature. | Leukemia & lymphoma 20041001 |
| Cladribine: from the bench to the bedside--focus on hairy cell leukemia. | Expert review of anticancer therapy 20041001 |
| Durable response but prolonged cytopenia after cladribine treatment in relapsed patients with indolent non-Hodgkin's lymphomas: results of a Japanese phase II study. | International journal of hematology 20041001 |
| Selective increase of dATP pools upon activation of deoxycytidine kinase in lymphocytes: implications in apoptosis. | Nucleosides, nucleotides & nucleic acids 20041001 |
| Fluorescence studies of substrate binding to human recombinant deoxycytidine kinase. | Nucleosides, nucleotides & nucleic acids 20041001 |
| Stimulation of deoxycytidine kinase results in prolonged maintenance of the enzyme activity. | Nucleosides, nucleotides & nucleic acids 20041001 |
| Clofarabine in adult acute leukemias: clinical success and pharmacokinetics. | Nucleosides, nucleotides & nucleic acids 20041001 |
| Effects of 2-chloro-2'-deoxyadenosine on the cell cycle in the human leukemia EHEB cell line. | Nucleosides, nucleotides & nucleic acids 20041001 |
| Modulation of cytarabine induced cytotoxicity using novel deoxynucleoside analogs in the HL60 cell line. | Nucleosides, nucleotides & nucleic acids 20041001 |
| An update: 12-year follow-up of patients with hairy cell leukemia following treatment with 2-chlorodeoxyadenosine. | Leukemia 20040901 |
| Cutaneous adverse reaction to 2-chlorodeoxyadenosine with histological flame figures in patients with chronic lymphocytic leukaemia. | Journal of the European Academy of Dermatology and Venereology : JEADV 20040901 |
| Characterization of a gemcitabine-resistant murine leukemic cell line: reversion of in vitro resistance by a mononucleotide prodrug. | Clinical cancer research : an official journal of the American Association for Cancer Research 20040815 |
| Influence of 2-chlorodeoxyadenosine (cladribine) on human erythrocytes. | The international journal of biochemistry & cell biology 20040801 |
| Electrophysiological characterization of a recombinant human Na+-coupled nucleoside transporter (hCNT1) produced in Xenopus oocytes. | The Journal of physiology 20040801 |
| Role of low-dose 2-CdA in refractory or resistant lymphoplasmocytic lymphoma. | Journal of chemotherapy (Florence, Italy) 20040801 |
| Mechanisms of cross-resistance between nucleoside analogues and vincristine or daunorubicin in leukemic cells. | Biochemical and biophysical research communications 20040730 |
| Cytotoxicity and pharmacokinetics of cladribine metabolite, 2-chloroadenine in patients with leukemia. | Cancer letters 20040716 |
| Metabolic response patterns of nucleotides in B-cell chronic lymphocytic leukaemias to cladribine, fludarabine and deoxycoformycin. | Leukemia research 20040701 |
| Efficacy of continuous infusion 2-CDA (cladribine) in pediatric patients with Langerhans cell histiocytosis. | Pediatric blood & cancer 20040701 |
| Activation of deoxycytidine kinase by protein kinase inhibitors and okadaic acid in leukemic cells. | Biochemical pharmacology 20040701 |
| Factors affecting bryostatin 1-enhanced 2-CdA cytotoxicity in resistant B-cell chronic lymphocytic leukemia. | International journal of molecular medicine 20040701 |
| ['Smoldering systemic mastocytosis. 'Successful therapy with cladribine]. | Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 20040701 |
| [Mastocytosis: advances in molecular diagnosis and therapeutics]. | Annales pharmaceutiques francaises 20040701 |
| Allogeneic hematopoietic stem cell transplantation with a reduced-intensity conditioning regimen for treatment of metastatic renal cell carcinoma: single institution experience with a minimum 1-year follow-up. | Experimental hematology 20040701 |
| Advances in chemotherapy for chronic lymphocytic leukemia. | Seminars in hematology 20040701 |
| [Hairy cell leukemia therapy by cladribine]. | Nihon rinsho. Japanese journal of clinical medicine 20040701 |
| T(11;18)-bearing pulmonary mucosa-associated lymphoid tissue lymphoma responding to cladribine. | International journal of hematology 20040701 |
| Clinical trials for malignant lymphoma in Japan. | Japanese journal of clinical oncology 20040701 |
| Upon drug-induced apoptosis in lymphoma cells X-linked inhibitor of apoptosis (XIAP) translocates from the cytosol to the nucleus. | Leukemia & lymphoma 20040701 |
| [Cladribine monotherapy for patients with relapsed or refractory indolent non-Hodgkin lymphoma]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 20040701 |
| Advances in the diagnosis and treatment of chronic lymphocytic leukemia. | Clinical advances in hematology & oncology : H&O 20040701 |
| Determination of the deoxycytidine kinase activity in cell homogenates with a non-radiochemical assay using reversed-phase high performance liquid chromatography; Identification of a novel metabolite of 2-chlorodeoxyadenosine. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20040615 |
| High incidence of complications after 2-chloro-2'-deoxyadenosine combined with cyclophosphamide in patients with advanced lymphoproliferative malignancies. | Annals of hematology 20040601 |
| Interleukin-8 and RANTES levels in patients with relapsing-remitting multiple sclerosis (RR-MS) treated with cladribine. | Acta neurologica Scandinavica 20040601 |
| Treatment of Erdheim-Chester disease with cladribine: a rational approach. | The British journal of ophthalmology 20040601 |
| Edema of the eyelids and sclera after rituximab infusion for orbital MALT lymphoma. | Haematologica 20040601 |
| [Successful induction and complete improvement of myelofibrosis and erythema nosodum with cladribine in a case of hairy cell leukemia]. | Gan to kagaku ryoho. Cancer & chemotherapy 20040601 |
| Purine nucleoside antimetabolites in development for the treatment of cancer. | Current opinion in investigational drugs (London, England : 2000) 20040601 |
| Metabolism of the antineoplastic and immunosuppressive drug 2-CdA (Leustatin) in animals and humans. | Xenobiotica; the fate of foreign compounds in biological systems 20040601 |
| Richter's syndrome in the brain first manifested as an ischaemic stroke. | Leukemia & lymphoma 20040601 |
| Addition of cladribine to daunorubicin and cytarabine increases complete remission rate after a single course of induction treatment in acute myeloid leukemia. Multicenter, phase III study. | Leukemia 20040501 |
| Reduced-intensity stem cell transplantation from an HLA-identical sibling donor in patients with myeloid malignancies. | Bone marrow transplantation 20040501 |
| Purine nucleoside analogues and combination therapies in B-cell chronic lymphocytic leukemia: dawn of a new era. | Leukemia research 20040501 |
| Systemic mastocytosis: current concepts and treatment advances. | Current hematology reports 20040501 |
| [Hairy cell leukemia, Japanese variant, successfully treated with cladribine]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 20040501 |
| Treatment of indolent non-Hodgkin's lymphoma with cladribine as single-agent therapy and in combination with mitoxantrone. | International journal of hematology 20040501 |
| Rituximab followed by cladribine in the treatment of heavily pretreated patients with indolent lymphoid malignancies. | Leukemia & lymphoma 20040501 |
| Epstein-Barr virus positive large B-cell lymphoma arising in a patient previously treated with Cladribine for hairy cell leukemia. | Leukemia & lymphoma 20040501 |
| Treatment of refractory neurosarcoidosis with cladribine. | The New England journal of medicine 20040422 |
| 2-Chloro-2'-deoxyadenosine synergistically enhances azidothymidine cytotoxicity in azidothymidine resistant T-lymphoid cells. | Biochemical and biophysical research communications 20040402 |
| Feasibility of reduced intensity hematopoietic stem cell transplantation from an HLA-matched unrelated donor. | Bone marrow transplantation 20040401 |
| Occurrence of a myelodysplastic syndrome (MDS) during first-line 2-chloro-deoxyadenosine (2-CDA) treatment of a low-grade gastrointestinal MALT lymphoma. Case report and review of the literature. | Haematologica 20040401 |
| Safety of rituximab therapy during the first trimester of pregnancy: a case history. | European journal of haematology 20040401 |
| Phase II trial of cladribine and cytarabine in relapsed or refractory myeloid malignancies. | Leukemia research 20040401 |
| Treatment of systemic mast cell disease: beyond interferon. | Leukemia research 20040301 |
| In vitro drug-resistance profile in infant acute lymphoblastic leukemia in relation to age, MLL rearrangements and immunophenotype. | Leukemia 20040301 |
| Determination of the in vivo effects of cladribine alone and its combination with cyclophosphamide or cyclophosphamide and mitoxantrone on Bax and Bcl-2 protein expression in B-CLL cells. | Oncology reports 20040301 |
| Long-term follow-up of front-line treatment of hairy cell leukemia with 2-chlorodeoxyadenosine. | Haematologica 20040301 |
| Activation of deoxycytidine kinase in lymphocytes is calcium dependent and involves a conformational change detectable by native immunostaining. | Biochemical pharmacology 20040301 |
| 2-Chloro-2'-deoxyadenosine: alteration of DNA:TATA element binding protein (TBP) interactions. | Journal of molecular modeling 20040201 |
| Cladribine activity in systemic mast cell disease: application of biochemistry in the modern era of molecular biology. | Leukemia research 20040201 |
| Treatment of systemic mast cell disease with 2-chlorodeoxyadenosine. | Leukemia research 20040201 |
| Second malignancies and Richter's syndrome in patients with chronic lymphocytic leukaemia treated with cladribine. | European journal of cancer (Oxford, England : 1990) 20040201 |
| Ex vivo drug resistance in childhood acute myeloid leukemia on relapse is not higher than at first diagnosis. | Pediatric blood & cancer 20040201 |
| Antitumor activity of sugar-modified cytosine nucleosides. | Cancer science 20040201 |
| Treatment of advanced mycosis fungoides/Sézary syndrome with fludarabine and potential adjunctive benefit to subsequent extracorporeal photochemotherapy. | The British journal of dermatology 20040201 |
| Clinical, genetic, and therapeutic insights into systemic mast cell disease. | Current opinion in hematology 20040101 |
| The antileukemia drug 2-chloro-2'-deoxyadenosine: an intrinsic transcriptional antagonist. | Molecular pharmacology 20040101 |
| Cladribine followed by autologous stem-cell transplantation in progressive multiple sclerosis. | Internal medicine journal 20040101 |
| Development of early neutropenic fever, with or without bacterial infection, is still a significant complication after reduced-intensity stem cell transplantation. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20040101 |
| Effect of 2-chlorodeoxyadenosine therapy on bone marrow fibrosis in hairy cell leukemia. | Neoplasma 20040101 |
| [Bone marrow fibrosis during therapy of hairy cell leukemia]. | Ceskoslovenska patologie 20040101 |
| Successful treatment of cutaneous langerhans cell histiocytosis with thalidomide. | Dermatology (Basel, Switzerland) 20040101 |
| Successful pregnancy after cladribine therapy for hairy cell leukemia. | Leukemia & lymphoma 20040101 |
| Alemtuzumab (Campath 1H) in hairy cell leukaemia relapsing after rituximab treatment. | The hematology journal : the official journal of the European Haematology Association 20040101 |
| Translocation t(11;18)(q21;q21) is not predictive of response to chemotherapy with 2CdA in patients with gastric MALT lymphoma. | Oncology 20040101 |
| Purine analogs in leukemia. | Advances in pharmacology (San Diego, Calif.) 20040101 |
| Acute respiratory failure associated with cladribine pneumonitis. | Internal medicine journal 20040101 |
| Evidence-based evaluation of immunomodulatory therapy for the cutaneous manifestations of lupus. | Advances in dermatology 20040101 |
| The influence of 2-chlorodeoxyadenosine (2-CdA) on the adenine energy charge and glutathione content of human erythrocytes. | Cell biology international 20040101 |
| 2-Chlorodeoxyadenosine alone and in combination with cyclophosphamide and mitoxantrone induce apoptosis in B chronic lymphocytic leukemia cells in vivo. | Cancer detection and prevention 20040101 |
| Histomorphometry of nuclei of proximal convoluted tubules epithelium of kidney of experimental animals after Cladribine (2-CdA) administration. | Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina 20040101 |
| Histomorphology of renal corpuscles of kidney of experimental animals after Cladribine (2-CdA) administration. | Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina 20040101 |
| Histomorphology of renal proximal convoluted tubules of kidney of experimental animals after Cladribine (2-CdA) administration. | Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina 20040101 |
| The ultrastructure of kidney renal corpuscles of experimental animals after Cladribine (2-CdA) administration. | Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina 20040101 |
| Ultrastructure of kidney renal proximal convoluted tubules of experimental animals after Cladribine (2-CdA) administration. | Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina 20040101 |
| Cladribine therapy for systemic mastocytosis. | Blood 20031215 |
| Increased remissions from one course for intermediate-dose cytosine arabinoside and idarubicin in elderly acute myeloid leukaemia when combined with cladribine. A randomized population-based phase II study. | British journal of haematology 20031201 |
| Prospective randomised phase II study of gemcitabine at standard or fixed dose rate schedule in unresectable hepatocellular carcinoma. | British journal of cancer 20031117 |
| Epstein-Barr virus-associated B-cell non-Hodgkin lymphoma following treatment of hairy cell leukemia with cladribine. | Blood 20031101 |
| Chronic myelomonocytic leukemia coexisting with B-cell chronic lymphocytic leukemia. | Leukemia & lymphoma 20031101 |
| Hairy cell leukemia and sarcoidosis: a case report and review of the literature. | Leukemia 20031001 |
| Mast cell proliferative disorders: current view on variants recognized by the World Health Organization. | Hematology/oncology clinics of North America 20031001 |
| [Immunohistochemical detection and quantification of minimal residual disease using DBA.44 antibodies in trephination biopsies of hairy cell leukemia]. | Ceskoslovenska patologie 20031001 |
| Pharmacological basis for cladribine resistance. | Leukemia & lymphoma 20031001 |
| A multicenter, open, non-comparative, phase II study of the combination of cladribine (2-chlorodeoxyadenosine), cytarabine, and G-CSF as induction therapy in refractory acute myeloid leukemia - a report of the Polish Adult Leukemia Group (PALG). | European journal of haematology 20030901 |
| Cutaneous reactions in hairy cell leukaemia treated with 2-chlorodeoxyadenosine and allopurinol. | British journal of haematology 20030901 |
| Synergistic effects of chemotherapeutic drugs in lymphoma cells are associated with down-regulation of inhibitor of apoptosis proteins (IAPs), prostate-apoptosis-response-gene 4 (Par-4), death-associated protein (Daxx) and with enforced caspase activation. | Biochemical pharmacology 20030901 |
| [Treatment of systemic mastocytosis]. | La Revue de medecine interne 20030901 |
| Immune reconstitution following reduced-intensity transplantation with cladribine, busulfan, and antithymocyte globulin: serial comparison with conventional myeloablative transplantation. | Bone marrow transplantation 20030901 |
| Disseminated zygomycosis: a rare cause of infection in patients with hematologic malignancies. | The Journal of trauma 20030901 |
| The influence of imatinib mesylate (STI571) used alone or in combination with purine nucleoside analogues on the normal and chronic myelogenous leukaemia progenitor cells in vitro. | Leukemia & lymphoma 20030901 |
| Effect of Aplidin in acute lymphoblastic leukaemia cells. | British journal of cancer 20030818 |
| Phase 2 study of rituximab in the treatment of cladribine-failed patients with hairy cell leukemia. | Blood 20030801 |
| Mitoxantrone and cytarabine induction, high-dose cytarabine, and etoposide intensification for pediatric patients with relapsed or refractory acute myeloid leukemia: Children's Cancer Group Study 2951. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030801 |
| Functional expression and characterization of a sodium-dependent nucleoside transporter hCNT2 cloned from human duodenum. | Biochemical and biophysical research communications 20030801 |
| Mantle cell lymphoma. | Current treatment options in oncology 20030801 |
| Hairy cell leukemia: an update. | Current opinion in hematology 20030701 |
| Diabetes insipidus and Langerhans cell histiocytosis: a case report of reversibility with 2-chlorodeoxyadenosine. | Journal of pediatric hematology/oncology 20030701 |
| Hairy cell leukaemia with advanced treatment - a case report. | Mymensingh medical journal : MMJ 20030701 |
| Role of IMP-selective 5'-nucleotidase (cN-II) in hematological malignancies. | Leukemia & lymphoma 20030701 |
| Increased sensitivity to gemcitabine of P-glycoprotein and multidrug resistance-associated protein-overexpressing human cancer cell lines. | British journal of cancer 20030616 |
| A key role for caspase-2 and caspase-3 in the apoptosis induced by 2-chloro-2'-deoxy-adenosine (cladribine) and 2-chloro-adenosine in human astrocytoma cells. | Molecular pharmacology 20030601 |
| Doxorubicin-resistant, MRP1-expressing U-1285 cells are sensitive to idarubicin. | Therapeutic drug monitoring 20030601 |
| Mechanism of action of purine analogues in chronic lymphocytic leukaemia. | British journal of haematology 20030601 |
| Gastrointestinal involvement in disseminated Langerhans cell histiocytosis (LCH) with durable complete response to 2-chlorodeoxyadenosine and high-dose cytarabine. | Journal of pediatric hematology/oncology 20030601 |
| Phase II study of cladribine (2-chlorodeoxyadenosine) in relapsed or refractory adult T-cell leukemia-lymphoma. | International journal of hematology 20030601 |
| Development of hairy cell leukemia in a patient treated with cytoreductive agents for essential thrombocythemia. | Leukemia & lymphoma 20030601 |
| Effect of gamma-irradiation on cladribine and cladribine-containing biodegradable copolymers. | Journal of controlled release : official journal of the Controlled Release Society 20030520 |
| Marked increase in serum IgM during treatment of Waldenstrom's macroglobulinemia with cladribine. | The New England journal of medicine 20030515 |
| Waldenstrom's macroglobulinemia: is there a place and time for a cease-fire? | Leukemia research 20030501 |
| Successful treatment of a patient with hairy cell leukemia and pentostatin-induced autoimmune thrombocytopenia with rituximab. | American journal of hematology 20030501 |
| Fighting leukemia. Survival rates have tripled thanks to new, more effective treatments. | Mayo Clinic women's healthsource 20030501 |
| Hodgkin's type of Richter's syndrome in familial chronic lymphocytic leukemia treated with cladribine and cyclophosphamide. | Leukemia & lymphoma 20030501 |
| Regulation of hairy-cell survival through constitutive activation of mitogen-activated protein kinase pathways. | Oncogene 20030417 |
| Indolent neuroendocrine tumor involving the bone marrow. A case report with a 9-year follow-up. | Archives of pathology & laboratory medicine 20030401 |
| Hairy cell leukemia variant developing in a background of polycythemia vera. | Archives of pathology & laboratory medicine 20030401 |
| Impact of graft-versus-host disease in reduced-intensity stem cell transplantation (RIST) for patients with haematological malignancies. | British journal of haematology 20030401 |
| Treatment recommendations in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia. | Seminars in oncology 20030401 |
| 2-Chlorodeoxyadenosine alone and in combination for previously untreated Waldenstrom's macroglobulinemia. | Seminars in oncology 20030401 |
| Hairy cell leukemia with concurrent cryptococcus infection. | American journal of hematology 20030301 |
| Extended follow-up of patients with hairy cell leukemia after treatment with cladribine. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030301 |
| Expression of deoxycytidine kinase in leukaemic cells compared with solid tumour cell lines, liver metastases and normal liver. | European journal of cancer (Oxford, England : 1990) 20030301 |
| 2-Chlorodeoxyadenosine therapy for disseminated Langerhans cell histiocytosis. | Mayo Clinic proceedings 20030301 |
| Comparison of cytotoxicity of 2-chloro- 2'-arabino-fluoro-2'-deoxyadenosine (clofarabine) with cladribine in mononuclear cells from patients with acute myeloid and chronic lymphocytic leukemia. | Haematologica 20030301 |
| The variant form of hairy-cell leukaemia. | Best practice & research. Clinical haematology 20030301 |
| Splenectomy and treatments of historical interest. | Best practice & research. Clinical haematology 20030301 |
| Interferon in the treatment of hairy-cell leukemia. | Best practice & research. Clinical haematology 20030301 |
| Hairy-cell leukaemia as a model for drug development. | Best practice & research. Clinical haematology 20030301 |
| Cladribine in the treatment of hairy-cell leukaemia. | Best practice & research. Clinical haematology 20030301 |
| Immunobiological treatments of hairy-cell leukaemia. | Best practice & research. Clinical haematology 20030301 |
| Purine nucleoside analogues in the treatment of myleoid leukemias. | Leukemia & lymphoma 20030301 |
| Successful treatment of Langerhans cell histiocytosis with 2-chlorodeoxyadenosine. | Respirology (Carlton, Vic.) 20030301 |
| Efficient syntheses of 2-chloro-2'-deoxyadenosine (cladribine) from 2'-deoxyguanosine(1). | The Journal of organic chemistry 20030207 |
| Efficacy of 2-chlorodeoxyadenosine in refractory factor VIII inhibitors in persons without hemophilia. | Blood 20030201 |
| Advances in the treatment of hairy-cell leukaemia. | The Lancet. Oncology 20030201 |
| A phase II study of cladribine treatment for fludarabine refractory B cell chronic lymphocytic leukemia: results from CALGB Study 9211. | Leukemia 20030201 |
| [Cladribine]. | Gan to kagaku ryoho. Cancer & chemotherapy 20030201 |
| Alkaline hydrolysis of cladribine. | Die Pharmazie 20030201 |
| CD4+ CD56+ neoplasia: clinical and biological features with emphasis on cytotoxic drug-induced apoptosis and expression of sialyl Lewis X. | Leukemia & lymphoma 20030201 |
| Synthesis and induction of apoptosis in B cell chronic leukemia by diosgenyl 2-amino-2-deoxy-beta-D-glucopyranoside hydrochloride and its derivatives. | Carbohydrate research 20030120 |
| The effects of cladribine and fludarabine on DNA methylation in K562 cells. | Biochemical pharmacology 20030115 |
| Down-regulation of deoxycytidine kinase in human leukemic cell lines resistant to cladribine and clofarabine and increased ribonucleotide reductase activity contributes to fludarabine resistance. | Biochemical pharmacology 20030115 |
| Influence of p53 and p21(WAF1) expression on sensitivity of cancer cells to cladribine. | Biochemical pharmacology 20030101 |
| Phase II study of cladribine and cyclophosphamide in patients with chronic lymphocytic leukemia and prolymphocytic leukemia. | Cancer 20030101 |
| Newer drugs for the treatment of lupus nephritis. | Drugs 20030101 |
| In AML cell lines Ara-C combined with purine analogues is able to exert synergistic as well as antagonistic effects on proliferation, apoptosis and disruption of mitochondrial membrane potential. | Leukemia & lymphoma 20030101 |
| The effect of cyclosporin A used alone and in combination with either 2-chlorodeoxyadenosine or fludarabine on normal and chronic myelogenous leukemia progenitors in vitro. | Archivum immunologiae et therapiae experimentalis 20030101 |
| Interventions for the prevention of brain atrophy in multiple sclerosis : current status. | CNS drugs 20030101 |
| p53 status and its in vitro relationship to radiosensitivity and chemosensitivity in lung cancer. | Anticancer research 20030101 |
| Nucleotide excision repair-deficient human cells in culture exhibit decreased survival after 2-chlorodeoxyadenosine treatment. | Anticancer research 20030101 |
| 2-Chloro-deoxyadenosine induces durable complete remission in Castleman's disease but may accelerate its transformation to non-Hodgkin's lymphoma. | Acta oncologica (Stockholm, Sweden) 20030101 |
| Hairy cell leukemia in father and son. | Medical oncology (Northwood, London, England) 20030101 |
| Treatment of cutaneous T-cell lymphomas with purine analogues (fludarabine and 2-chlorodeoxyadenosine). | Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20030101 |
| Rituximab: a useful drug for a repeatedly relapsed hairy cell leukemia patient. | Annals of hematology 20021201 |
| [Immunosuppressive medication in multiple sclerosis]. | Revista de neurologia 20021201 |
| Relationships of in vitro sensitivities tested with nine drugs and two types of irradiation in chronic lymphocytic leukemia. | Leukemia research 20021101 |
| Cladribine induces immunophenotypical changes in bone marrow mast cells from mastocytosis. Report of a case of mastocytosis associated with a lymphoplasmacytic lymphoma. | Leukemia research 20021101 |
| Cellular drug resistance in childhood acute myeloid leukemia is related to chromosomal abnormalities. | Blood 20021101 |
| Pharmacokinetics of 2-chlorodeoxyadenosine in a child undergoing hemofiltration and hemodialysis for acute renal failure. | Journal of pediatric hematology/oncology 20021101 |
| Complete remission of chronic plaque psoriasis and gastric marginal zone B-cell lymphoma of MALT type after treatment with 2-chlorodeoxyadenosine. | Annals of hematology 20021101 |
| Cladribine in the treatment of IgM paraproteinemic polyneuropathy. | Neurology 20021022 |
| Interim comparison of a continuous infusion versus a short daily infusion of cytarabine given in combination with cladribine for pediatric acute myeloid leukemia. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20021015 |
| Role of caspases and apoptosis-inducing factor (AIF) in cladribine-induced apoptosis of B cell chronic lymphocytic leukemia. | Leukemia 20021001 |
| Successful treatment of leukaemia cutis with cladribine in a patient with B-cell chronic lymphocytic leukaemia. | The British journal of dermatology 20021001 |
| Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine) by subcutaneous bolus injection: a phase II study. | Annals of oncology : official journal of the European Society for Medical Oncology 20021001 |
| [Pulmonary localization of hairy cell leukemia]. | La Revue de medecine interne 20021001 |
| Langerhans cell histiocytosis in a patient with systemic lupus erythematosus: a clonal disease responding to treatment with cladribine, and cyclophosphamide. | Leukemia & lymphoma 20021001 |
| Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type with cladribine: a phase II study. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020915 |
| Adenine and deazaadenine nucleoside and deoxynucleoside analogues: inhibition of viral replication of sheep MVV (in vitro model for HIV) and bovine BHV-1. | Bioorganic & medicinal chemistry 20020901 |
| Response of idiopathic hypereosinophilic syndrome to treatment with imatinib mesylate. | Leukemia research 20020901 |
| Waldenström's macroglobulinaemia. | Blood reviews 20020901 |
| Reduced-dose cladribine (2-CdA) plus mitoxantrone is effective in the treatment of mantle-cell and low-grade non-Hodgkin's lymphoma. | European journal of cancer (Oxford, England : 1990) 20020901 |
| B-chronic lymphocytic leukemia: practical aspects. | Hematological oncology 20020901 |
| Cytotoxic effect of cyclosporin A alone and in combination with 2-chlorodeoxyadenosine against P388 murine leukemia in vivo. | Medical science monitor : international medical journal of experimental and clinical research 20020901 |
| [The BCTRIMS Expanded Consensus on treatment of multiple sclerosis: I. The evidences for the use of immunosuppressive agents, plasma exchange and autologous hematopoietic stem cell transplantation]. | Arquivos de neuro-psiquiatria 20020901 |
| Evaluation of apoptosis induced in vitro by cladribine (2-CdA) combined with anthracyclines in lymphocytes from patients with B-cell chronic lymphocytic leukemia. | Annals of hematology 20020901 |
| Ex vivo drug resistance profile in childhood acute myelogenous leukemia: no drug is more effective in comparison to acute lymphoblastic leukemia. | Leukemia & lymphoma 20020901 |
| Specificity of human and rat orthologs of the concentrative nucleoside transporter, SPNT. | American journal of physiology. Renal physiology 20020801 |
| Simultaneous diagnosis of hairy cell leukemia and chronic lymphocytic leukemia/small lymphocytic lymphoma: a frequent association? | Leukemia 20020801 |
| Bendamustine in the treatment of chronic lymphocytic leukemia: results and future perspectives. | Seminars in oncology 20020801 |
| Systemic vasculitis complicating hairy cell leukaemia treatment with cladribine. | Clinical and laboratory haematology 20020801 |
| 2-chloro-2'-deoxyadenosine in the treatment of Sjögren's syndrome-associated B cell lymphoproliferation. | Arthritis and rheumatism 20020801 |
| Successful treatment with 2-chlorodeoxyadenosine of secondary lesions of the central nervous system in low-grade lymphoid malignancies. | American journal of hematology 20020801 |
| [Immunosuppressants and multiple sclerosis]. | Revista de neurologia 20020801 |
| Waldenström's macroglobulinemia: a review of therapy. | Leukemia & lymphoma 20020801 |
| Mini-transplantation strategy for solid tumors. | International journal of hematology 20020801 |
| Evolving role of ribonucleoside reductase inhibitors in hematologic malignancies. | Expert review of anticancer therapy 20020801 |
| Immune response by host after allogeneic chondrocyte transplant to the cartilage. | Microscopy research and technique 20020701 |
| Exposure-disease continuum for 2-chloro-2'-deoxyadenosine (2-CdA), a prototype teratogen: induction of lumbar hernia in the rat and species comparison for the teratogenic responses. | Teratology 20020701 |
| [Successful treatment of hairy cell leukemia prolymphocytic variant with 2'-deoxycoformycin]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 20020701 |
| Re-treatment with cladribine-based regimens in relapsed patients with B-cell chronic lymphocytic leukemia. Efficacy and toxicity in comparison with previous treatment. | European journal of haematology 20020701 |
| Alkylating agents and nucleoside analogues in the treatment of B cell chronic lymphocytic leukemia. | Leukemia 20020601 |
| Bax expression correlates with cellular drug sensitivity to doxorubicin, cyclophosphamide and chlorambucil but not fludarabine, cladribine or corticosteroids in B cell chronic lymphocytic leukemia. | Leukemia 20020601 |
| Treatment of late-stage Sézary syndrome with 2-Chlorodeoxyadenosine. | International journal of dermatology 20020601 |
| Myelodysplasia terminating in acute myeloid leukemia in a hairy cell leukemia patient treated with 2-deoxycoformycin. | Leukemia & lymphoma 20020601 |
| Anthracyclines potentiate activity against murine leukemias L1210 and P388 in vivo and in vitro. | European journal of haematology 20020601 |
| Aggressive growth of epithelial carcinomas following treatment with nucleoside analogues. | American journal of hematology 20020501 |
| [Therapeutic effectiveness of cladribine and cellular immunodeficiency--related effects in hairy-cell leukemia?]. | Vnitrni lekarstvi 20020501 |
| [Hairy cell leukemia treated with cladribine]. | Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20020430 |
| Therapeutic potential of a reduced-intensity preparative regimen for allogeneic transplantation with cladribine, busulfan, and antithymocyte globulin against advanced/refractory acute leukemia/lymphoma. | Clinical cancer research : an official journal of the American Association for Cancer Research 20020401 |
| The role of mitoxantrone in non-Hodgkin's lymphoma. | Oncology (Williston Park, N.Y.) 20020401 |
| Gateways to Clinical Trials. | Methods and findings in experimental and clinical pharmacology 20020401 |
| Cytotoxicity of 2-chlorodeoxyadenosine and arabinosylcytosine in leukaemic lymphoblasts from paediatric patients: significance of cellular nucleoside transporter content. | British journal of haematology 20020301 |
| Oral cladribine for B-cell chronic lymphocytic leukaemia: report of a phase II trial with a 3-d, 3-weekly schedule in untreated and pretreated patients, and a long-term follow-up of 126 previously untreated patients. | British journal of haematology 20020301 |
| Severe decrease in peripheral blood dendritic cells in hairy cell leukaemia. | British journal of haematology 20020301 |
| Treatment of children with Langerhans cell histiocytosis with 2-chlorodeoxyadenosine. | American journal of hematology 20020301 |
| Widespread skin-limited adult Langerhans cell histiocytosis: long-term follow-up with good response to interferon alpha. | Clinical and experimental dermatology 20020301 |
| Radiation therapy and combination of cladribine, cyclophosphamide, and prednisone as treatment of Bing-Neel syndrome: Case report and review of the literature. | American journal of hematology 20020201 |
| Suspected delayed immune recovery against cytomegalovirus after reduced-intensity stem cell transplantation using anti-thymocyte globulin. | Bone marrow transplantation 20020201 |
| Therapeutic approaches to secondary progressive multiple sclerosis. | Multiple sclerosis (Houndmills, Basingstoke, England) 20020201 |
| Fludarabine therapy in Waldenström's macroglobulinemia patients treated previously with 2-chlorodeoxyadenosine. | Leukemia & lymphoma 20020201 |
| Cladribine underdosing in hairy-cell leukemia: a cause for apparent response failure. | Leukemia & lymphoma 20020201 |
| Induction of apoptosis by cladribine (2-CdA), gemcitabine and other chemotherapeutic drugs on CD34+/CD38+ and CD34+/CD38- hematopoietic progenitor cells: selective effects of doxorubicin and 2-CdA with protection of immature cells. | Leukemia & lymphoma 20020201 |
| Resistance of leukemic cells to 2-chlorodeoxyadenosine is due to a lack of calcium-dependent cytochrome c release. | Blood 20020115 |
| Anti-CD20 antibody (IDEC-C2B8, rituximab) enhances efficacy of cytotoxic drugs on neoplastic lymphocytes in vitro: role of cytokines, complement, and caspases. | Haematologica 20020101 |
| Cladribine (2-chlorodeoxyadenosine) therapy in hairy cell leukemia variant. A report of three cases. | Haematologica 20020101 |
| 2-Chloro-2'-deoxyadenosine inhibits DNA repair synthesis and potentiates UVC cytotoxicity in chronic lymphocytic leukemia B lymphocytes. | Leukemia 20020101 |
| Use of 2-chlorodeoxyadenosine to treat infantile myofibromatosis. | Journal of pediatric hematology/oncology 20020101 |
| Immunosuppression with limited toxicity: the characteristics of nucleoside analogs and anti-lymphocyte antibodies used in non-myeloablative hematopoietic cell transplantation. | Cancer treatment and research 20020101 |
| Cladribine decreases the level of angiogenic factors in patients with chronic lymphocytic leukemia. | Neoplasma 20020101 |
| Therapeutic approaches in multiple sclerosis: lessons from failed and interrupted treatment trials. | BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 20020101 |
| 5'-Esters of 2'-deoxyadenosine and 2-chloro-2'-deoxyadenosine with cell differentiation-provoking agents. | Acta biochimica Polonica 20020101 |
| In vitro release of cytotoxic nucleoside analogs from lactide-caprolactone and lactide-glycolide copolymers. | Acta biochimica Polonica 20020101 |
| Waldenström's macroglobulinemia. | Clinical journal of oncology nursing 20020101 |
| Cladribine combined with cyclophosphamide is highly effective in the treatment of chronic lymphocytic leukemia. | The hematology journal : the official journal of the European Haematology Association 20020101 |
| The role of membrane transporters in cellular resistance to anticancer nucleoside drugs. | Cancer treatment and research 20020101 |
| Hepatosplenic gamma delta T-cell lymphoma with leukemic phase successfully treated with 2-chlorodeoxyadenosine. | Haematologia 20020101 |
| Histological examination of the extrabulbar segment of the optic nerve in experimental animals after administration of Cladribine. | Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina 20020101 |
| Influence of the new medicine--2-CDA (Cladribine) on the ultrastructure of the extrabulbar segment of the optic nerve in rabbits of New Zealand breed. | Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina 20020101 |
| Histological examination of the retinal ganglion layer in rabbits after experimental administration of the new immunosuppressive medicine--Cladribine. | Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina 20020101 |
| Ultrastructural changes of retinal ganglion cells in rabbits of New Zealand breed after experimental administration of 2-CDA (Cladribine). | Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina 20020101 |
| Histological examination of the lacrimal gland after experimental administration of Cladribine. | Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina 20020101 |
| Autoanti-D in a patient after cladribine treatment for lymphoplasmocytic lymphoma. | Immunohematology 20020101 |
| Hematological effects of intermittent 2-hour infusions of cladribine in multiple sclerosis patients: a comparison of 2 dosage patterns. | International journal of hematology 20011201 |
| Cladribine. Ortho Biotech Inc. | Current opinion in investigational drugs (London, England : 2000) 20011201 |
| Successful treatment of refractory Langerhans cell histiocytosis with unrelated cord blood transplantation. | Journal of pediatric hematology/oncology 20011201 |
| Treatment of hairy-cell leukemia. | The New England journal of medicine 20011115 |
| Acquisition of human concentrative nucleoside transporter 2 (hcnt2) activity by gene transfer confers sensitivity to fluoropyrimidine nucleosides in drug-resistant leukemia cells. | Molecular pharmacology 20011101 |
| Cladribine induces apoptosis in human leukaemia cells by caspase-dependent and -independent pathways acting on mitochondria. | The Biochemical journal 20011101 |
| Resistance to 2-chloro-2'-deoxyadenosine of the human B-cell leukemia cell line EHEB. | Clinical cancer research : an official journal of the American Association for Cancer Research 20011101 |
| Prolymphocytic leukemia or prolymphocytic transformation of mantle cell lymphoma. | American journal of clinical pathology 20011101 |
| Cladribine combined with cyclophosphamide and mitoxantrone as front-line therapy in chronic lymphocytic leukemia. | Leukemia 20011001 |
| Efficacy of anti-CD20 monoclonal antibodies (Mabthera) in patients with progressed hairy cell leukemia. | Haematologica 20011001 |
| Identification and characterization of human deoxyguanosine kinase cDNA fragments. | Cancer letters 20010920 |
| Exposure-disease continuum for 2-chloro-2'-deoxyadenosine, a prototype ocular teratogen. 1. Dose-response analysis. | Teratology 20010901 |
| Impact of treatment on the outcome of acute myeloid leukemia with inversion 16: a single institution's experience. | Leukemia 20010901 |
| [Recent progress in the treatment of malignant lymphoma]. | Gan to kagaku ryoho. Cancer & chemotherapy 20010901 |
| Sin of omission? Pharmaceutical trade group failed to disclose that ad subject was employee. | Modern healthcare 20010806 |
| The diagnosis of hairy cell leukemia can be established by flow cytometric analysis of peripheral blood, even in patients with low levels of circulating malignant cells. | American journal of hematology 20010801 |
| A phase II study of sequential combination chemotherapy with cyclophosphamide, prednisone, and 2-chlorodeoxyadenosine in previously untreated patients with chronic lymphocytic leukemia. | Leukemia 20010801 |
| Effect of cladribine treatment on beta-2 microglobulin and soluble intercellular adhesion molecule 1 (ICAM-1) in patients with multiple sclerosis. | Folia morphologica 20010801 |
| Richter's syndrome following cladribine therapy for chronic lymphocytic leukemia first manifested as pathologic fracture of the femur. | Leukemia & lymphoma 20010801 |
| Infectious complications of purine analog therapy. | Current opinion in infectious diseases 20010801 |
| Efficacy of the anti-CD22 recombinant immunotoxin BL22 in chemotherapy-resistant hairy-cell leukemia. | The New England journal of medicine 20010726 |
| Multiple sclerosis: recent developments in neuropathology, pathogenesis, magnetic resonance imaging studies and treatment. | Current opinion in neurology 20010601 |
| Experience with 2-chlorodeoxyadenosine in previously untreated children with newly diagnosed acute myeloid leukemia and myelodysplastic diseases. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010601 |
| Nucleoside analogues: mechanisms of drug resistance and reversal strategies. | Leukemia 20010601 |
| Nucleoside analogues in the treatment of haematological malignancies. | Expert opinion on pharmacotherapy 20010601 |
| Treatment options in Waldenström's macroglobulinaemia: the role of the purine analogues. | Expert opinion on pharmacotherapy 20010601 |
| Gynecomastia in a case of hairy cell leukaemia--cladribine induced? | Leukemia & lymphoma 20010601 |
| Hairy cell leukemia. | Current treatment options in oncology 20010601 |
| Novel treatment strategies in chronic lymphocytic leukemia. | Current oncology reports 20010501 |
| Therapeutic advances in the treatment of hairy cell leukemia. | Leukemia research 20010501 |
| Systematic review of immunomodulatory drugs for the treatment of people with multiple sclerosis: Is there good quality evidence on effectiveness and cost? | Journal of neurology, neurosurgery, and psychiatry 20010501 |
| Successful application of nonmyeloablative transplantation for paroxysmal nocturnal hemoglobinuria. | Experimental hematology 20010501 |
| Does intensive treatment with high dose chlorambucil and prednisone as first line and cladribine as second line influence the survival of the patients with chronic lymphocytic leukemia? | Leukemia & lymphoma 20010501 |
| Pharmacological basis for cladribine resistance in a human acute T lymphoblastic leukaemia cell line selected for resistance to etoposide. | British journal of haematology 20010501 |
| Immunologic therapy for secondary and primary progressive multiple sclerosis. | Current neurology and neuroscience reports 20010501 |
| Immunomodulatory drugs for multiple sclerosis: a systematic review of clinical and cost effectiveness. | Expert opinion on pharmacotherapy 20010401 |
| Human cytosolic 5'-nucleotidase I: characterization and role in nucleoside analog resistance. | The Journal of biological chemistry 20010330 |
| [Results of treatment with 2-chlorodeoxyadenosine in refractory or relapsed Langerhans cell histiocytosis. Study of 9 patients]. | Medicina clinica 20010310 |
| Immunosuppressive and cytotoxic drugs in the treatment of rheumatic skin disorders. | Seminars in cutaneous medicine and surgery 20010301 |
| Effective treatment with rituximab in a patient with refractory prolymphocytoid transformed B-chronic lymphocytic leukemia and Evans syndrome. | Annals of hematology 20010301 |
| Pure red cell aplasia in patients with chronic lymphocytic leukaemia treated with cladribine. | British journal of haematology 20010301 |
| Cladribine in combination with mitoxantrone and cyclophosphamide(CMC) in the treatment of heavily pre-treated patients with advanced indolent lymphoid malignancies. | European journal of haematology 20010301 |
| Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation. | Blood 20010201 |
| Candida tropicalis and Penicillium marneffei mixed fungaemia in a patient with Waldenström's macroglobulinaemia. | European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20010201 |
| Purpuric rash following treatment with 2-chlorodeoxyadenosine. | Clinical and laboratory haematology 20010201 |
| Second primary tumors and immune phenomena after fludarabine or 2-chloro-2'-deoxyadenosine treatment. | Leukemia & lymphoma 20010201 |
| Cladribine in the treatment of chronic lymphocytic leukemia. | Leukemia & lymphoma 20010201 |
| Treatment of systemic mast-cell disease with cladribine. | The New England journal of medicine 20010125 |
| Activation of deoxycytidine kinase by inhibition of DNA synthesis in human lymphocytes. | Biochemical pharmacology 20010115 |
| Unexpectedly high incidence of hypoplastic/aplastic foci in bone marrow biopsies of hairy cell leukemia patients in remission following 2-chlorodeoxyadenosine therapy. | European journal of haematology 20010101 |
| Effect of immunosuppressive cladribine treatment on serum leucocytes system in two-year clinical trial in patients with chronic progressive multiple sclerosis. | Medical science monitor : international medical journal of experimental and clinical research 20010101 |
| Langerhans cell histiocytosis: central nervous system involvement treated successfully with 2-chlorodeoxyadenosine. | Pediatric hematology and oncology 20010101 |
| 2-chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia. | Zhonghua yi xue za zhi = Chinese medical journal; Free China ed 20010101 |
| Achieving optimal outcomes in chronic lymphocytic leukaemia. | Drugs 20010101 |
| Modulation of human deoxycytidine kinase activity as a response to cellular stress induced by NaF. | Acta biochimica Polonica 20010101 |
| A systematic overview of chemotherapy effects in B-cell chronic lymphocytic leukaemia. | Acta oncologica (Stockholm, Sweden) 20010101 |
| Cladribine combined with mitoxantrone in the treatment of blastic phase of chronic myeloid leukemia. | Neoplasma 20010101 |
| Flow cytometry of peripheral blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells, lymphocyte subsets and detection of minimal residual disease after treatment. | Neoplasma 20010101 |
| Plasmablastic lymphoma in a patient with chronic lymphocytic leukemia heavily pretreated with cladribine (2-CdA): an unusual variant of Richter's syndrome. | European journal of haematology 20010101 |
| [Lupus nephritis: treatments for today and tomorrow]. | Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20010101 |
| [Nucleoside analogues--new drugs for the treatment of lymphatic cancers]. | Duodecim; laaketieteellinen aikakauskirja 20010101 |
| Guillain-Barre syndrome following 2-chlorodeoxyadenosine treatment for Hairy Cell Leukemia. | Leukemia & lymphoma 20001101 |
| Severe skin rash in two consecutive patients treated with 2-chlorodeoxyadenosine for hairy cell leukaemia at a single institution. | Clinical and laboratory haematology 20000401 |
| Delayed onset of autoimmune hemolytic anemia complicating cladribine therapy for Waldenström macroglobulinemia. | Leukemia & lymphoma 20000301 |
| Expression and release of chemokines associated with apoptotic cell death in human promonocytic U937 cells and peripheral blood mononuclear cells. | European journal of immunology 19991001 |
| Paradoxical immunologic effects of 2-CdA therapy: comment on the article by Davis et al. | Arthritis and rheumatism 19980901 |
| Induction of an apoptotic program in cell-free extracts by 2-chloro-2'-deoxyadenosine 5'-triphosphate and cytochrome c. | Proceedings of the National Academy of Sciences of the United States of America 19980804 |
| Autoimmune haemolysis in patients with B-CLL treated with chlorodeoxyadenosine (CDA). | Leukemia & lymphoma 19980401 |
| Apoptosis- and necrosis-inducing potential of cladribine, cytarabine, cisplatin, and 5-fluorouracil in vitro: a quantitative pharmacodynamic model. | Cancer chemotherapy and pharmacology 19980101 |
| 2-chlorodeoxyadenosine administration to patients with the myeloid blast phase of chronic myelogenous leukemia. | Leukemia & lymphoma 19971201 |
| The development of congestive cardiac failure in a patient with hairy cell leukemia treated with 2-chlorodeoxyadenosine. | Leukemia & lymphoma 19970701 |
| Fulminant 2-chlorodeoxyadenosine-related peripheral neuropathy in a patient with paraneoplastic neurological syndrome associated with lymphoma. | Leukemia & lymphoma 19960401 |
| 2-Chlorodeoxyadenosine activity in patients with untreated, indolent non-Hodgkin's lymphoma. | Blood 19950901 |
| A phase I and pharmacokinetics study of 2-chlorodeoxyadenosine in patients with solid tumors. | Cancer chemotherapy and pharmacology 19950101 |
| Apoptosis induction with three nucleoside analogs on freshly isolated B-chronic lymphocytic leukemia cells. | American journal of hematology 19941201 |
| Therapeutic and neurotoxic effects of 2-chlorodeoxyadenosine in adults with acute myeloid leukemia. | Blood 19941115 |
| Clinical and toxicological aspects of the antineoplastic drug cladribine: a review. | Annals of hematology 19941101 |
| 2-Chlorodeoxyadenosine therapy in advanced chronic lymphocytic leukaemia. | Nouvelle revue francaise d'hematologie 19940801 |
| A phase I study of intermittent infusion cladribine in patients with solid tumors. | Cancer 19940701 |
| Synthesis and biologic activity of 2'-fluoro-2-halo derivatives of 9-beta-D-arabinofuranosyladenine. | Journal of medicinal chemistry 19920124 |
| Binding of thyroid microsomes by lymphocytes from patients with thyroid disease and normal subjects. | Clinical and experimental immunology 19760101 |